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ABSTRACT 
Gating mechanisms underlying deactivation slowing by atrial fibrillation mutations and 
small-molecule activators of KCNQ1 
Gary Peng 
 
Ion channels are membrane proteins that facilitate electrical signaling in important 
physiological processes, such as the rhythmic contraction of the heart.  KCNQ1 is the pore-
forming subunit of a voltage-gated potassium channel that assembles with the β-subunit KCNE1 
in the heart to generate the IKs current, which is critical to cardiac action potential repolarization 
and electrical conduction in the heart.  Mutations in IKs subunits can cause potentially lethal 
arrhythmia, including long QT syndrome, short QT syndrome, and atrial fibrillation.  Each 
channel consists of four voltage-sensing domains and a central pore through which ions 
permeate.  Voltage-dependent gating occurs when movement of voltage sensors cause pore 
opening/closing through coupling mechanisms.  Although KCNQ1 by itself is able to form a 
voltage-dependent potassium channel, its assembly with KCNE1 is essential to generating the 
physiologically critical cardiac IKs current, characterized by a delay in the onset of activation, an 
increase in current amplitude, and a depolarizing shift in the current-voltage relationship.  
KCNE1 is thought to have multiple points of contact with KCNQ1 that reside within both the 
voltage-sensing domain and the pore domain, allowing for extensive modulation of channel 
function. 
Atrial fibrillation is the most common cardiac arrhythmia and affects more than 3 million 
adults in the United States.  Much rarer, genetic forms of atrial fibrillation have been associated 
with gain-of-function mutations in KCNQ1, such as two adjacent mutations, S140G and V141M.  
Both mutations drastically slow channel deactivation, which underlies their pathophysiology.  
Deactivation slowing causes accumulation of open channels in the context of repeated 
stimulation, which abnormally increases the repolarizing K+ current, excessively shortens the 
action potential duration, and predisposes to re-entry arrhythmia such as atrial fibrillation.  
Although both mutations are located in the voltage-sensing domain, their mechanisms of action 
remain unknown.  Understanding the gating mechanisms underlying deactivation slowing may 
provide key insights for the development of mechanism-based pharmacologic therapies for 
arrhythmias associated with KCNQ1 mutations. 
In addition to gain-of-function mutations, molecular activators of KCNQ1 can slow 
deactivation and increase channel activity. An existing problem in the pharmacologic treatment 
of arrhythmia is that many antiarrhythmic drugs do not have specific targets and cause undesired 
side effects such as additional arrhythmia.  Thus, developing mechanism-based therapies may 
optimize clinical treatment for patients with specific forms of channel dysfunction.  Two 
KCNQ1 activators, ML277 and R-L3, have been previously shown to slow current deactivation, 
but the underlying gating mechanisms remain known.  Although these modulators are unlikely to 
serve directly as antiarrhythmic therapy, investigating their mechanisms will likely provide 
fundamental insights on channel modulation and guide future efforts to develop personalized 
therapies for arrhythmia, such as congenital long QT syndrome. 
Given the central importance of deactivation slowing in both pathophysiology and 
pharmacology, we focused on investigating gating mechanisms that underlie deactivation 
slowing.  To this end, we utilized voltage clamp fluorometry, a technique that simultaneously 
assays for voltage sensor movement and ionic current through the channel pore.  In Chapter 1, 
we begin our study by examining the gating mechanisms of KCNQ1 atrial fibrillation mutations 
in the absence of KCNE1.  We show that S140G slows voltage sensor deactivation, which 
indirectly slows current deactivation.  On the other hand, V141M neither slows voltage sensor 
nor current deactivation.  This is followed by Chapter 2, where we examine the gating 
mechanisms underlying deactivation slowing by atrial fibrillation mutations in the presence of 
KCNE1.  We show that both S140G and V141M slow IKs deactivation by slowing pore closing 
and altering voltage sensor-pore coupling.  Based on these findings, we proposed a molecular 
mechanism in which both mutations disrupt the orientation of KCNE1 relative to KCNQ1 and 
thus impede pore closing, implying that future efforts to modulate KCNQ1 function can benefit 
from targeting the β-subunit.  Finally, in Chapter 3, we explore the gating mechanisms 
underlying deactivation slowing for two small-molecule activators of KCNQ1.  We show that 
ML277 predominantly slows pore transitions, whereas R-L3 slows voltage sensor deactivation, 
which indirectly slows current deactivation.  Taken together, these studies guide future efforts to 
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The Cardiac Action Potential 
Electrical signals propagate through the heart to cause the coordinated and rhythmic 
contraction of cardiac muscles, allowing efficient pumping of blood into the vasculature1.  
Normal electrical activity in the heart originates in the sinoatrial node, propagates through the 
atria to reach the atrioventricular node, and then travels through the bundle of His, the bundle 
branches, and the Perkinje fibers to reach the ventricles.  Electrical stimulation of 
cardiomyocytes results in a sequence of changes in the cellular membrane potential over time 
known as the cardiac action potential.  These changes in the membrane potential are driven by 
the summation of a variety of cellular ionic currents with different time-dependent profiles (Fig. 
I1).  Ionic currents flow through membrane proteins known as ion channels, whose unique 
structural, gating, and pharmacologic properties give rise to distinct types of currents. 
The action potential in a normal ventricular cardiomyocyte begins at a resting potential of 
approximately -85 mV2.  This potential is close to the potassium equilibrium potential because of 
open inwardly rectifying potassium channels.  Upon electrical stimulation, voltage-gated sodium 
channels, predominantly NaV1.5, open to allow influx of sodium ions.  This depolarizes the cell 
to approximately +30 mV in a rapid upstroke.  The rate of upstroke correlates with the speed of 
electrical propagation across the cardiac tissue and can be modulated.  This is followed by the 
inactivation of sodium currents and activation of transient outward potassium currents, which 
briefly repolarize the cell and give rise to a notch in the action potential.  Next is the plateau 
phase, where there is concomitant activation of L-type calcium channels (predominantly CaV1.2) 
and the delayed rectifier potassium currents (IKs and IKr).  The delicate balance between inward 
calcium currents and outward potassium currents maintain the plateau potential.  Calcium influx 
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also triggers the release of calcium from the sarcoplasmic reticulum into the cytosol, a process 
known as calcium-induced calcium release.  This process is critical to excitation-contraction 
coupling.  Released calcium binds to troponin-C, allows myosin to interact with actin, and causes 
cardiomyocytes to contract.  Eventually, inactivation of calcium channels causes potassium 
currents to dominate and repolarize the membrane potential back to resting level.  There is a 
refractory period in which sodium channels have yet to recover from inactivation and thus is 
unresponsive to stimulation.  The cell remains at the resting potential for some time, during 
which cardiomyocytes relax and allow heart chambers to fill with blood before the next cycle of 
contraction.   
Figure I1.  The cardiac ventricular and atrial action potential.  The ventricular (a) and atrial 
(b) action potential are depicted as membrane potential vs. time.  The time-dependent profiles of 
ionic currents that contribute each action potential are shown underneath.  IKs, the slow delayed 
rectifier potassium current, is an outward current that contributes to both the plateau phase and the 
repolarization phase of the ventricular action potential, but contributes less to the action potential 
of atrial cardiomyocytes. Figure from Nerbonne, J. M. & Kass, R. S., 2005. 
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The action potential duration (APD) varies between cells from different regions of the 
heart.  For example, atrial cardiomyocytes have shorter APD than ventricular cardiomyocytes 
due to differences in underlying ionic currents1.  In particular, IK(ultrarapid) is an atrial-specific 
outward potassium current that is thought to contribute to larger repolarizing currents and shorter 
APD in atrial cardiomyocytes1.  Although IKs is also present in atrial cardiomyocytes, it is 
thought to play a smaller role in atrial repolarization.  
Control of the APD is critical to normal cardiac function.  Excessive prolongation or 
shortening of the APD can predispose individuals to potentially lethal arrhythmia2.  Action 
potential prolongation can manifest on an electrocardiogram (EKG) as a prolonged QT interval, 
such as in patients with long QT syndrome (LQTS)2.  Drug-induced LQTS results from drugs 
which inadvertently inhibit ionic currents (particularly IKr), whereas congenital LQTS often 
results from disease mutations in ion channels that underlie cardiac currents such as IKs, IKr, and 
INa.  When the action potential is prolonged, sodium and calcium currents may recover from 
inactivation prior to termination of the action potential, leading to an abnormal pattern of 
depolarization known as early afterdepolarization (EAD).  EADs can cause degeneration of 
cardiac rhythm into a sinusoidal wave pattern known as torsades de pointes, which may lead to 
ventricular fibrillation and sudden cardiac death.  An alternative mechanism for arrhythmic 
events is delayed afterdepolarization (DAD), which results from intracellular calcium overload 
that occurs under prolonged action potentials.  On the other hand, pathological shortening of the 
action potential can decrease the refractory period of cardiomyocytes and predispose to re-entry 
arrhythmia such as atrial fibrillation.  This mechanism is also thought to underlie arrhythmic 
events seen in patients with short QT syndrome (SQTS).  Given the association between 
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abnormal APD and disease, maintenance of normal APD is critically important to normal cardiac 
function. 
 
IKs, the slow delayed rectifier potassium current 
IKs, an outward current with unique kinetic and voltage-dependent properties, plays a key 
role in the repolarization of the cardiac action potential1.  In 1969, the delayed rectifier potassium 
current was studied in sheep Purkinje fibers and shown to possess two kinetically distinct 
components3.  These currents were later pharmacologically dissected in guinea pig ventricular 
myocytes into IKs and IKr4.  IKs is slowly-activating and most prominent during the plateau and 
repolarizing phases of the cardiac action potential, where it contributes to counterbalancing 
calcium influx and repolarizing the action potential.  Expression of IKs has been demonstrated in 
both human atrial and ventricular myocytes5-7.  In addition, it has also been measured in 
cardiomyocytes from non-human mammalian species including dogs8-12 and rabbits13.  On the 
other hand, IKs is expressed at very low levels or absent in mouse hearts14. 
The central role of IKs in normal cardiac conduction became more evident when it was 
discovered that mutations causing loss of IKs function leads to congenital LQTS (Fig. I2).  Jervell 
and Lange-Nielsen syndrome (JLNS), the autosomal recessive form of congenital LQTS, has so 
far only been associated with mutations causing loss of IKs function15,16.  An additional feature of 
JLNS is sensorineural deafness, which is consistent with the finding that IKs is expressed in the 
inner ear and facilitates K+ secretion into the endolymph17.  Nonetheless, the majority of LQTS 
arising from IKs mutations are autosomal dominant in a condition known as Romano-Ward 
syndrome, which is not associated with deafness18,19.  
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Importantly, IKs is subject to 
upregulation by β-adrenergic stimulation to 
control APD in the face of sympathetic nerve 
activity20,21.  During sympathetic activation 
such as in exercise, adrenergic stimulation 
augments IKs, which counterbalances the 
concomitant increase in calcium currents, 
prevents prolongation of the cardiac APD, and 
allows for adequate diastolic filling times 
between heart beats22.  However, insufficient 
IKs activation such as in LQT1 results in 
failure to counterbalance the calcium influx, 
prolonging the APD and increasing susceptibility to arrhythmia.  This is consistent with exercise 
being a key trigger of cardiac events in LQT1 patients23.  Normal IKs function is therefore critical 
to maintaining normal electrical activity of the heart, especially under stressful conditions.  
Given this, understanding the properties of ion channels that underlie physiologically important 
currents such as IKs would be an important step to investigating mechanisms of disease. 
 
General Properties of Ion Channels 
Ion channels are proteins on the plasma membrane that underlie many ionic currents in 
the heart.  Coordination among ion channels facilitates the ionic balance necessary for the 
generation of an action potential and normal electrical propagation through excitable membranes.  
These channels create specialized pores in the membrane through which ions may passively 
Figure I2.  Simulating the effect of IKs loss-of-
function on action potential duration.  (a) Simulated 
steady-state action potential waveform for control (WT) 
and following IKs loss-of-function (LQT1).  (b) 
Corresponding IKs current profile for wildtype and in 
loss-of-function.  LQT1 mutations reduce the amplitude 
of the outward IKs, thus prolonging the APD.  Figure 
from Nerbonne, J. M. & Kass, R. S., 2005. 
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diffuse down their electrochemical gradient at high rates.  The channel pore contains a selectivity 
filter with distinctive atomic components to allow for selective permeation of ions24-26.   
The ion channel pore can open and close in response to a variety of signals.  Some ion 
channels exhibit voltage-dependent gating, in which changes in membrane potential cause 
conformational changes in voltage-sensing domains and lead to pore opening or closing27.  
Examples include voltage-gated sodium and potassium channels, whose gating properties make 
them useful in the propagation of action potentials.  In contrast, ligand-gated ion channels 
undergo conformational changes upon binding to signaling molecules28.  These channels are 
particularly important in neuronal synaptic transmission and signaling at the neuromuscular 
junction.  On the other hand, mechanosensitive channels are opened by physical stretch and play 
important roles in touch and hearing29.  A group of ion channels known as inward rectifier 
potassium channels allow influx potassium ions but do not conduct outward currents.  
Rectification is not an intrinsic property of these ion channels; instead, it is due to intracellular 
magnesium ions that plug the pore at depolarized voltages.  Thus, although these channels lack 
intrinsic gating mechanisms, conductance of ions appears voltage-dependent30.  To add even 
greater diversity, some channels display combinations of the abovementioned gating properties. 
Diversity in ion channel function also depends on a variety of molecular entities that 
contribute to their trafficking, stabilization, signaling, and function1.  For example, accessory 
subunits are proteins that can associate with ion channels to modify their properties and generate 
physiologically significant currents31,32.  Mutations in accessory subunits are implicated in 
genetic diseases, underscoring their physiological importance33.  In addition, accessory subunits 
can alter ion channel response to activators and inhibitors and therefore are important to consider 
in designing drugs that target physiologically relevant ion channels34.  In addition to accessory 
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subunits, cytoskeleton-associated proteins such as ankyrin and syntrophin are known to interact 
with and stabilize ion channels in the plasma membrane2.  Mutations in ankyrin and syntrophin 
are known to disrupt ion channel function and are associated with LQTS.  Thus, ion channels 
interact with surrounding proteins to fulfill their varied physiological roles.  The nature of these 
interactions are oftentimes informed by structural information. 
 
Structure of Voltage-gated Potassium Channels 
The superfamily of voltage-gated potassium (KV) channels plays central roles in 
physiology, particularly in repolarizing action potentials in excitable tissue.  In general, each 
voltage-gated potassium channel consists of four identical subunits, and each subunit contains 
six transmembrane helices (Fig. I3 a).  The S1-S4 helices comprise the voltage-sensing domain 
(VSD) and includes the positively charged S4 that respond to changes in membrane potential.  
The helices S5, S6, and the linker in-between comprise the pore domain and line the pathway of 
ion permeation.  This linker is known as the P-loop and contains the selectivity filter.  Between 
the VSD and the pore domain is the S4-S5 linker, which physically couples the VSD to the pore.  
Structural insights on the KV superfamily are mainly derived from crystal structures of the 
Shaker channel, which was the first cloned KV channel and is considered the prototype of the KV 
family35,36.  These structural insights shed light on channel function and are summarized below. 
The pore of the KV1.2 (Shaker) channel is located at the center and is formed by the pore 
domains of four channel subunits26 (Fig. I3 b).  The structure of the pore is similar to that of 
KcsA, a previously crystallized voltage-independent potassium channel37.  The selectivity filter 
is located near the extracellular side of the channel and allows for the selective permeation of 
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potassium ions (Fig. I3 c).  It contains rings of 
electronegative oxygen atoms arranged in specific 
atomic dimensions that coordinate with potassium ions 
and provides the necessary stabilization energy to 
remove water molecules38.  As water molecules are 
stripped away, potassium ions pass through the filter.  
Larger ions do not pass through the filter as easily 
because of geometric constraints.  On the other hand, 
smaller ions (ex.  Na+) do not coordinate with the 
oxygen atoms in the selectivity filter as tightly as K+ 
and therefore are less energetically favored to lose 
water molecules.  As a result, the Na+-H2O complex is 
too large to pass through the selectivity filter.  The 
selective permeation of K+ ions allow KV channels to 
effectively repolarize the cell membrane to negative 
potentials.  
Beneath the selectivity filter is a water-filled 
central cavity whose properties can influence ion 
conduction37 (Fig. I3 c).  For example, a higher density 
of negative charges lining the central cavity is thought 
to attract K+ ions and contribute to increased K+ 
conductance in BK channels39.  Underneath the central 
cavity, the intracellular ends of four S6 helices cross 
Figure I3.  Structure of voltage-gated 
potassium channels.  (a) Topology of a 
generic voltage-gated potassium channel.  (b) 
Cartoon representation of the 3-dimentional 
structure of a generic voltage-gated 
potassium channel.  (c) The 3-D crystal 
structure of a potassium channel pore.  Only 
two subunits are shown for clarity.  The 
precise geometry of the selectivity filter 
provides energetic stabilization for potassium 
ions (purple), resulting in selective 
permeation.  Figure from Jeremiah Osteen. 
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each other to form the inner helix-bundle, which constricts and dilates to close and open the 
channel respectively.  This is thought to be the activation gate of the channel.  Gating can be 
controlled by movement of the VSD, which is coupled to the gate.   
Each KV1.2 (Shaker) channel contains four VSDs located at the perimeter of the channel 
pore26 (Fig. I3 b).  The VSDs appear to be structurally independent from the pore with only few 
points of contact.  In fact, chimeric channels containing VSDs of one protein and the pore 
domains of another can undergo voltage-dependent gating, supporting the modular nature of 
VSDs40,41.  The S4-S5 linker provides a physical connection between the VSD and the channel 
gate, thereby coupling voltage sensor movement to pore opening/closing.  Domain-swapping is 
observed in KV1.2, such that the voltage-sensing domain of one subunit is spatially juxtaposed to 
the pore-forming helices of an adjacent subunit.  The domain-swapping leads to a geometric 
orientation that is thought to be important in VSD-pore coupling42. 
Pore domains and voltage-sensing domains are shared features among voltage-dependent 
ion channels.  As such, crystallographic studies of KV1.2 have provided a critically important 
framework for interpreting structural and functional information on other channels in the KV 
superfamily43, including KCNQ1.  They have been particularly useful for describing the 
structural underpinnings of voltage-dependent gating processes, helping to align previously 
obtained functional data while guiding further investigation of gating mechanisms in KV 
channels. 
 
Mechanisms of Gating in Voltage-Dependent Channels 
In 1952, Hodgkin and Huxley published a series of seminal studies on voltage-dependent 
potassium and sodium currents in the squid giant axon using the voltage-clamp technique44-49.  
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Based on kinetic analyses, they developed kinetic models that postulated the presence of “gating 
particles” which undergo transitions in response to changes in membrane potential and cause 
current activation.  Their prediction of 4 gating particles for the potassium current turned out to 
be remarkably consistent with the stoichiometry of 4 voltage sensors per channel.  Their 
contributions created a framework of voltage-dependent gating that exerted widespread influence 
on the field of electrophysiology and would remain relevant in modern views of channel gating 
mechanisms. 
 
S4 as the voltage sensor 
Since the early studies of Hodgkin and Huxley, extensive efforts have been devoted to 
understanding how voltage-sensing occurs in ion channels.  The gating particle proposed by 
Hodgkin and Huxley is now understood to be the S4 helix in voltage-gated ion channels, which 
contains positively charged residues that allow it to sense changes in membrane potential.  The 
number of gating charges can be measured by blocking ionic currents through the channel pore 
and integrating the remaining gating current over time.  Using this technique, the number of 
gating charges in the Shaker channel has been measured to be approximately 13e050-52.  Charge 
neutralization experiments show that the first four arginines on S4 are responsible for these 
gating charges.  While some of the arginines are stabilized by electrostatic interactions with 
negatively charged residues on the S2 transmembrane helix53,54, others face toward membrane 
lipids27.  The balance of electrostatic and hydrophobic interactions is thought to be important in 
shaping the energetic landscape of voltage sensors27. 
Movement of the S4 through the plasma membrane has been demonstrated through a 
variety of experiments, though the extent of movement has been controversial.  For example, S4 
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residues accessible to cysteine modification reagents from the intracellular side of the Shaker 
channel becomes accessible from the extracellular side following outward displacement of the 
S455, suggesting a large movement (>10 Å) of the S4 during activation.  Similarly, experiments 
examining the rate of cysteine modification at a site close to the S4 suggest that the S4 
translocates by >12 Å relative to the pore56.  However, other studies of the Shaker channel 
suggest that the S4 undergoes small displacement within a concentrated electric field57-60 created 
by aqueous crevices that penetrate into the voltage-sensing domain.  This model is supported by 
data suggesting the presence of a hydrophilic permeation pathway across the VSD that is 
normally blocked by native channel residues61-63.  Despite evidence from biophysical and 
biochemical studies, insight on the degree and nature of S4 movement has been hindered by a 
lack in crystallographic evidence.  Because proteins are crystallized in the absence of an external 
electric field, nearly all crystal structures of potassium channels contain activated conformations 
of S443.  While molecular dynamic simulations have been useful in elucidating details of S4 
movement64, future studies may be required to provide conclusive answers. 
 
S4 coupling to the channel pore 
Whether large or small, S4 movement is coupled to the channel pore to control pore 
opening/closing.  In the Shaker channel, voltage sensor-pore coupling is achieved by the S4-S5 
linker, an amphipathic helix on the intracellular side of the plasma membrane that physically 
connects the S4 to the inner-helix bundle, also known as the channel gate65.  Yet, coupling 
mechanisms vary between channels.  The hERG channel, in contrast to Shaker, does not require 
an intact S4-S5 linker for voltage-dependent gating66.  Instead, coupling may be mediated by 
domain-domain electrostatic interactions requiring membrane phospholipids.  In addition, the 
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HCN channel is a cationic channel that is opened by hyperpolarization rather than depolarization, 
and generates the “funny current” that underlies the automaticity of cardiac pacemaker cells.  
Interestingly, the voltage sensors of HCN, like those of KV channels, still move outward in 
response to depolarization, suggesting that an altered voltage sensor-pore coupling mechanism 
underlies its reversed voltage-dependence67.  Variations in coupling mechanisms therefore 
contribute to diversity in gating behavior that exists among voltage-dependent channels. 
 
Inactivation 
Some voltage-gated ion channels can inactivate and become non-conducting during 
sustained depolarization.  Inactivation is therefore distinct from deactivation, where the channel 
gate closes upon repolarization.  There are several types of inactivation with different underlying 
mechanisms.  Clay Armstrong noticed that for potassium channels that do not inactivate, the 
addition of a TEA+ molecule covalently bonded to a carbon chain to the intracellular solution can 
mimic channel inactivation68.  Based on this result and others, Armstrong and Bezanilla 
proposed the “ball and chain” model of inactivation, in which a peptide “ball” linked to the 
channel by a peptide “chain” swings over to physically obstruct the channel pore69.  After the 
Shaker channel was cloned, its N-terminus was found to contain multiple hydrophobic residues 
that are thought to plug the channel pore and cause inactivation70.  This gave rise to the term N-
type inactivation.  This model was confirmed by the crystal structure of KV1.2 in which the N-
terminal peptide can fit snugly inside the pore to block conduction26.  The other well studied 
form of inactivation in KV channels is C-type inactivation, which is slower than N-type 
inactivation and is caused by a rearrangement of the channel pore and selectivity filter71,72.  
Interestingly, C-type inactivation is slowed by increasing extracellular K+ concentration, which 
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may be attributed increased rate of K+ binding to the mouth of the pore and stabilization of the 
open conformation73.  C-type inactivation endows the hERG channel with an inward rectifying 
property74,75, which is important physiologically.  The hERG channel underlies the IKr current, 
which is relatively small at depolarized potentials during the plateau phase of the cardiac action 
potential.  However, as repolarization begins, hERG channels recover from inactivation, 
prominently increasing IKr and quickly restoring cells to the resting potential. 
 
Kinetic models of voltage-dependent gating 
Kinetic processes such as S4 movement, pore opening/closing and inactivation can be 
represented in Markov models to simulate ion channel function.  These kinetic models use a set 
of channel states and transitions defined by rate constants to describe gating.  Kinetic models are 
always simplifications of reality, but the advantages of modeling are multifold.  First, a good 
model provides a framework for interpreting electrophysiological data and sheds light on channel 
gating mechanisms.  Second, models can be used to infer the mechanisms of effect of channel 
mutations and drugs that perturb channel gating.  Third, models of individual ion channels can be 
incorporated into larger, in silico cellular models of action potential to study arrhythmogenesis.   
When Hodgkin and Huxley studied the kinetics of voltage-dependent sodium and 
potassium currents in the squid giant axon, they proposed kinetic models to describe their 
observations and infer gating mechanisms.  In order to simulate the potassium current, they 
utilized a model containing four identical gating particles that can activate or deactivate in 
response to changes in voltage.  Activation and deactivation are transitions governed by rate 
constants49.  In their kinetic scheme, the potassium currents turn on once all four particles are 
activated.  On the other hand, sodium currents can be simulated if one of the four gating particles 
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was substituted by an inactivation particle.  These models provided an early picture of channel 
gating that aligns remarkably well with present understanding.  Kinetic models are therefore a 
useful tool to understanding gating processes that underlie channel function. 
The accuracy of a kinetic model depends on the amount and accuracy of data used to 
constrain it.  In addition to the kinetics of activation and deactivation, other biophysical 
properties such as steady-state activation and gating currents can used to constrain a kinetic 
model76.  Furthermore, mutagenesis can be used to dissect state transitions that are otherwise 
difficult to distinguish in the wildtype channel77.  These techniques led to a kinetic model of the 
Shaker channel in which four voltage sensors activate independently of one another.  
Furthermore, the model describes a two-step activation for each voltage sensor.  Once all voltage 
sensors are fully activated, a final cooperative step leads to channel opening.  As new 
constraining data are obtained from functional experiments, kinetic models can undergo further 
refinement and improvement. 
Variations in kinetic gating schemes reflect the functional diversity of voltage-gated 
channels.  Whereas the Shaker channel requires full activation of all voltage sensors prior to 
channel opening, functional data for the BK channel mSlo are consistent with an allosteric model 
of gating.  In this gating scheme, independent activation of each voltage sensor increases the 
open probability78,79.  An additional property of BK channels is calcium-dependent activation, 
which mediates important physiological processes such as spike frequency adaptation in 
neurons80.  The allosteric model of mSlo accounts for calcium-dependent activation and suggests 
that calcium binds to open states to stabilize activation81.  In addition to BK channels, the gating 
properties of HCN is also consistent with an allosteric gating scheme82.  However, in the case of 
HCN, voltage sensor activation promotes channel closing, not opening, resulting in a reversed 
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voltage-dependence.  Thus, differences in voltage-dependent gating schemes reflect the diversity 
of ion channels which are unique adapted to their physiological roles.   
In addition to elucidating diversity of gating processes between different ion channels, 
kinetic models have provided insights on how accessory subunits modulate channel gating.  For 
example, the β-subunit KCNE1 drastically alters the biophysical properties of KCNQ1 to 
generate the slowed delayed rectifier current, IKs.  Multiple studies have utilized kinetic modeling 
to elucidate the effects of KCNE1 on KCNQ1 gating, in particular the alteration in coupling 
between voltage sensors and pore83,84.  Below is a summary of the molecular and biophysical 
properties of channel subunits underlying IKs before an in-depth review of IKs gating 
mechanisms.  
 
Molecular and biophysical properties of KCNQ1 and IKs 
A pioneering step in identifying the ion channel underlying the IKs current was the 
discovery that the KCNQ1 (KVLQT1) gene is linked to long QT syndrome type 1 and encodes a 
voltage-gated potassium channel85.  The current conducted by this channel is minimally 
inactivating and its activation is relatively fast compared with any previously known current in 
the heart.  However, soon it was shown that KCNQ1 together with the accessory protein KCNE1 
(minK) generates IKs31,32.  While KCNE1 had previously been thought to independently form a 
potassium channel86,87, it was confirmed that KCNQ1 is actually the α- or pore-forming subunit 
of IKs while KCNE1 is a critical β- or modulatory subunit.  Co-expression of KCNQ1 with 
KCNE1 generates the hallmark IKs current with slow activation.  KCNQ1 and KCNE1 are 
expressed in all four chambers in the heart88, as well as the inner ear89,90, where IKs is thought to 
play a role in K+ secretion into the endolymph17.  This explains the observation that congenital 
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deafness is a key feature of JLNS.  In addition, KCNQ1 and KCNE1 are expressed elsewhere in 
the body, including the pancreas, the kidneys, and the brain91. 
 
KCNQ1, the pore-forming subunit 
Four subunits of KCNQ1 come together to form a channel that is capable of voltage-
dependent gating (Fig. I4 b).  Each KCNQ1 subunit, like most voltage-gated potassium channels, 
consists of six transmembrane helices85 (Fig. I4 a).  The helices S1-S4 comprise the voltage-
sensing domain.  In particular, the S4 helix contains positive charges and moves outward in 
response to membrane depolarization similar to other KV channels92-94.  Following the voltage-
sensing domain is the pore domain, which consists of the S5, P-loop, and S6.  Furthermore, the 
cytoplasmic linker between S4 and S5 plays important roles in voltage sensor-pore coupling and 
voltage-dependent gating95-97, similar to other voltage-gated channels98-100.  The C-terminal 
domain (CTD) of KCNQ1 is large and contains 4 intracellular α-helices referred to as A-D.  A 
wide range of functions has been attributed to the CTD including calmodulin binding, interaction 
with β-subunits and scaffolding proteins, as well as channel assembly and trafficking101,102.  
Other members of the KCNQ family (KCNQ2-5) share between 40-60% sequence homology 
with KCNQ1.  Their transmembrane regions are highly conserved, but other regions such as the 
C-terminal domains are relatively variable103.  In particular, KCNQ2 and KCNQ3 are widely 
expressed in the brain and can harbor mutations associated with neonatal epilepsy104-107. 
 
KCNQ1 voltage-dependent gating 
In the absence of β-subunits, KCNQ1 generates time-dependent currents in response to 
depolarization.  Its kinetics of activation and deactivation are slow compared with most voltage-
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gated potassium channels.  For instance, wildtype KCNQ1 expressed in Xenopus oocytes reaches 
near steady state on the order of seconds at +40 mV31 (Fig. I4 b).  In comparison, at the same 
voltage, the prototypical Shaker channel reaches maximal activation on the order of 10’s of 
milliseconds and then rapidly inactivates108.  Gating currents in KCNQ1 are small and difficult to 
measure, suggesting that KCNQ1 voltage sensor movement is also relatively slow compared 
with other channels83,109.  In addition, KCNQ1 displays a relative paucity of positively charged 
Figure I4.  The IKs macromolecular complex and PKA-mediated 
regulation. (a) Topology of KCNQ1, KCNE1, and associated proteins that 
participate in adrenergic regulation.  (b-c) Single pulse recordings of KCNQ1 
either expressed alone (b) or co-expressed with KCNE1 (c) in Xenopus 
oocytes.  (d) Dialysis with 200 µM cAMP and 0.2 µM okadaic acid (OA) 
slows deactivation and increases IKs amplitude.  IKs was heterologously 
expressed in CHO cells.  Panel (d) from Chen, L. et al. 2005. 
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residues on its S4 compared with other channels, further contributing to small gating currents.  
This relative paucity in gating charges may contribute to the gating flexibility that KCNQ1 
exhibits when modulated by β-subunits.  For instance, KCNE3 converts KCNQ1 into a 
constitutively active channel to facilitate intestinal chloride secretion110.  Previous studies have 
shown that KCNE3 stabilizes voltage sensor activation through electrostatic interactions between 
positive charges on S4 and negative charges at the extracellular end of the KCNE3 
transmembrane region111.  Such a constitutive mode of gating contrasts greatly with the voltage-
dependent behavior of KCNQ1 alone and is altogether different from the slowly activating IKs 
generated by co-expression with KCNE1. 
Remarkable insight into the gating processes of KCNQ1 comes from voltage clamp 
fluorometry (VCF), a technique that allows for simultaneous measurement of ionic current with 
voltage sensor movement.  This fluorescence-based technique is particularly useful as it 
overcomes the issue of small gating currents that makes it otherwise difficult to study S4 
movement in KCNQ1.  Initially, the technique was developed to study S4 movement in the 
Shaker channel and helped confirm S4 as the voltage sensor112,113.  The technique involves 
engineering a cysteine residue at a particular site of interest and covalently attaching a 
fluorophore.  Conformational changes involving the labeled site alters the hydrophobicity of the 
surrounding environment, leading to changes in fluorescence intensity.  Fluorescence changes 
can be measured in real time together with ionic currents.  Although cysteine accessibility 
experiments also assay for protein conformational changes, they require alteration of channel 
function during the course of the experiment, whereas VCF often imposes minimal changes to 
protein function.  Since its initial development, VCF has been utilized to study S4 movement in a 
variety of ion channels, including NaV1.5114,115, CaV1.2116, hERG117-119, and HCN120.   
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Previous VCF studies demonstrate an allosteric gating mechanism for KCNQ1121.  To 
report S4 movement in KCNQ1, Osteen et al. attached a fluorophore to an engineered cysteine 
residue at the S3-S4 linker of KCNQ1.  By altering S4 movement using mutations and 
selectively labeling channel subunits, Osteen et al. showed that the four S4’s of KCNQ1 move 
independently of one another.  Furthermore, locking two of four voltage sensors in the activated 
state enhances constitutive activation, suggesting that KCNQ1’s pore can open without complete 
activation of all voltage sensors.  In addition, the mutation L251A alters the coupling between 
the voltage sensor and the pore such that voltage sensor activation precedes pore opening, 
resulting in a slowly activating current that resembles IKs.  These results can be explained by an 
allosteric model where independent activation of each voltage sensor increases the open 
probability of the channel.  Furthermore, the model does not require activation of all four voltage 
sensors for channels to open.  In addition, the model suggests that voltage sensor-pore coupling 
in KCNQ1 is relatively weak compared with Shaker and may underlie dramatic changes in the 
channel gating behavior caused by modulatory subunits such as KCNE1122. 
Voltage sensor-pore coupling mechanisms allow voltage sensor movements to induce 
pore motions and have been studied in great detail for KCNQ1.  The S4-S5 linker physically 
interacts with the activation gate and is thought to be a critical mediator of coupling in KCNQ1.  
Choveau et al. showed that the S4-S5 linker can reversibly bind to the S6 C-terminus, which is 
the activation gate of the channel97.  In a different study, Labro et al. used double mutant cycle 
analysis to demonstrate interactions between residues in the S4-S5 linker and those in the S6 C-
terminus96.  In addition to mechanical coupling mediated by the S4-S5 linker, the lipid molecule 
phosphatidylinositol 4,5-bisphosphate (PIP2) is necessary for voltage sensor-pore coupling in 
KCNQ1.  PIP2 is found in the inner leaflet of plasma membranes123 and can regulate a variety of 
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ion channels124-129.  PIP2 mainly binds to KCNQ1 at its cytoplasmic loops and at the C-terminal 
region near S695,130,131, regions that define the interface between the VSD and the pore 
domain97,132.  PIP2 binding is mediated by electrostatic interactions between its anionic lipid 
headgroup and positively charged channel residues133.  Zaydman et al. devised a VCF 
experiment to show that PIP2 is necessary for voltage sensor-pore coupling95.  He first showed 
that the pore-opening mutation L353K stabilizes voltage sensors in the activated conformation.  
This is because coupling between voltage sensors and the pore is bidirectional, such that a pore 
effect can influence voltage sensor movement.  However, depletion of PIP2 abolishes L353K’s 
effect on voltage sensors, indicating that PIP2 is necessary for coupling.  Furthermore, rundown 
of PIP2 in the cell membrane reduces the current amplitude of KCNQ1 both in the presence and 
absence of KCNE1134 as a result of uncoupling the pore from voltage sensors.  Additional 
molecular dynamics studies suggest that in KNCQ1, voltage sensor-pore coupling mediated by 
the S4-S5 linker is relatively weak compared to other channels130.  As such, PIP2 plays a more 
prominent role in coupling for KCNQ1 compared with other channels.  Whether PIP2-dependent 
function represents a physiological mechanism to control or modulate IKs remains to be 
demonstrated. 
 
KCNE1, the β-subunit 
Co-expression of KCNE1 with KCNQ1 drastically alters channel function to generate IKs.  
Most prominently, assembly with KCNE1 leads to a delay in the onset of activation (Fig. I4 c), 
an increase in channel amplitude, as well as a depolarizing shift in the current-voltage 
relationship31,32.  This results in a channel that, compared with most other voltage-gated 
potassium channels, activates at more positive voltages and with slower kinetics.  These 
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properties allow IKs to be most activated toward the end 
of the plateau phase of the action potential, where it 
critically contributes to repolarization.  KCNE1 
contains 129 amino acids and consists of a single 
transmembrane helix, an extracellular N-terminus and 
an intracellular C-terminus86.  A number of positively 
charged residues in the C-terminus are positioned 
closely to the cell membrane and recruit PIP2 through 
electrostatic interactions, thereby augmenting current 
amplitude134.  KCNE1 is thought to have extensive 
contact with KCNQ1 including the voltage-sensing 
domain83,135-139, the pore domain135,140,141, the S4-S5 linker142, as well as the CTD143,144.  
Residues on KCNE1 can crosslink with both S1 and S6 of KCNQ1, suggesting that it is located 
in a cleft between the voltage-sensing domain and pore domain of different KCNQ1 
subunits135,139 (Fig. I5).  From this position, KCNE1 can potentially modulate multiple aspects 
KCNQ1 gating, including voltage sensor movement, pore transitions, and coupling.  With 
respect to the stoichiometry of KCNE1 to KCNQ1, some studies suggest a fixed 2:4 ratio145,146 
while others suggest a flexibility in stoichiometry up to 4:4 that contributes to modulation of 
assembled channels147-149.  Although three other members of the KCNE family, KCNE2-
KCNE4, are also expressed in the heart88 and are capable of modulating KCNQ1 
activity88,110,150,151, whether they associate with KCNQ1 in vivo in the heart to contribute 
potassium currents remains to be explored. 
 
Figure I5.  The location of KCNE1 
relative to KCNQ1 according to cysteine 
crosslinking.  Previous crosslinking 
studies are consistent with location of 
KCNE1 (black circle) in a cleft between 
the S1 and S6 helix of two different 
subunits.  Figure modified from Chung, D. 
Y. et al. 2009. 
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IKs voltage-dependent gating 
The ability for KCNE1 to drastically alter the ionic current of KCNQ1 is important to 
generating the slowly activating IKs in the heart.  Yet, a number of questions arose regarding the 
underlying gating modifications imposed by KCNE1.  For example, it was previously unclear 
whether the delay in the onset of IKs activation is due to a slowing in voltage sensor activation.  
Initial cysteine modification studies showed that the voltage-dependent modification of a 
cysteine residue introduced to the S4 (A226C) was slowed 13 times when KCNE1 was co-
expressed94, suggesting that KCNE1 slows voltage sensor activation.  In addition, a VCF study 
that labelled the V221C residue in the S3-S4 linker with the fluorophore Tetramethylrhodamine-
5-maleimide (TMRM) showed that KCNE1 slows S4 activation109.  However, additional studies 
showed that S4 activation is actually minimally slowed by KCNE1.  Rocheleau et al. showed 
that cysteine modification of the S4 occurs even when IKs is depolarized at short pulses of 0.1 s, 
suggesting that S4 activation is relatively fast93.  The previously observed slowing of cysteine 
modification rate in the presence of KCNE1 can be explained by hindered accessibility of the 
modification reagent to its target site.   
Additional VCF measurement of S4 movement demonstrated that voltage sensor 
activation is faster than current activation83,138.  In these studies, the G219C residue in the S3-S4 
linker was labelled with the fluorophore Alexa 488-maleimide to assay for voltage sensor 
movement.  By measuring the voltage-dependence of activation for fluorescence and 
conductance, the studies showed that KCNE1 splits fluorescence activation into two distinct 
components.  The first component occurs at more hyperpolarized potentials and represents 
voltage sensor movement while the pore remains closed.  The second component at more 
depolarized potentials is thought to represent S4 conformational change occurring 
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simultaneously with gate activation and exhibits slower activation kinetics compared with the 
first component.  Subsequent gating charge measurement showed that the majority of charge 
movement occurs during the first component of S4 activation83.  Movement of the S4 in the 
absence of channel opening explains the Cole-Moore shift that occurs in the presence of KCNE1, 
in which a hyperpolarizing prepulse while channels are closed slows subsequent current 
activation upon depolarization.  Because voltage sensors deactivate more fully during the 
hyperpolarizing prepulse, more time is required for subsequent activation and channel opening 
during the depolarizing pulse.  In addition, the second component of fluorescence observed in 
these studies is consistent with previous VCF results using the TMRM fluorophore, suggesting 
that TMRM labelling misses the first component of S4 activation but shows the second, slower 
component.   
Based on the two-component S4 activation observed, Barro-Soria et al. proposed a 
kinetic model in which four voltage sensors first independently activate while the pore remains 
closed before a second concerted movement that opens the pore83.  Kinetic simulations from this 
gating scheme are consistent with experimental data.  Compared with the allosteric gating 
scheme of KCNQ1 in the absence of KCNE1, these results suggest that KCNE1 has a major 
effect on voltage sensor-pore coupling.  Whereas KCNQ1 in the absence of KCNE1 can open 
when some of its voltage sensors activate, KCNE1 suppresses channel opening until all four 
voltage sensors have activated. 
Molecular interactions between the S4 and surrounding transmembrane helices can 
impede or guide its movement during channel activation.  For example, Nakajo and Kubo 
showed that in the presence of KCNE1, steric collisions between the bulky residues F232 on S4 
and F279 on S5 impede S4 activation and right-shift the voltage-dependence of channel 
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activation.  This steric interaction between S4 and S5 is only prominent in the presence of 
KCNE1, suggesting that in KCNQ1 alone there is flexibility in S4 motion such that during 
activation it avoids collision with S5.  The presence of KCNE1 may restrict the flexibility of S4 
motion such that it collides with S5 and thereby destabilizes activation.   
Additional evidence suggests that S4 arginines form state-dependent electrostatic 
interactions with the negatively charged residue E160 on the neighboring S2 helix.  The 
particular charge-pair formed depends on the conformational state of S4.  For example, E160 
interaction with R228 stabilizes the resting state, whereas E160-R237 stabilizes the activated 
state152.  Furthermore, the R231 residue, located between R228 and R237, interacts with E160 to 
stabilize what is considered the intermediate voltage sensor state84,153.  These three distinct S4 
interactions can explain the two-component S4 activation in IKs: voltage sensors first activate to 
the intermediate state, then enter the fully activated state.  In addition, channels locked in distinct 
S4 states exhibit distinct pore properties such selective permeability84, illustrating that S4 motion 
influences the pore.  Given these insights, Zaydman et al. proposed a kinetic model to explain 
gating processes in both KCNQ1 alone and KCNQ1+KCNE184.  For KCNQ1 alone, the pore 
opens when some voltage sensors enter the intermediate state.  Co-assembly with KCNE1 has 
minimal effect on S4 movement itself, but changes voltage sensor-pore coupling such 
intermediate S4 activation no longer opens the channel.  This model agrees with the model of 
Barro-Soria et al. in that KCNE1 has a critical impact on the coupling between S4 movement 
and the channel pore.  While the exact molecular interactions that mediate KCNE1’s effect 
remain to be explored, mechanistic understanding of channel gating provides a framework for 
interpreting how these mechanisms can be perturbed by, for example, mutations, pharmacologic 
modulators, and signaling pathways. 
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Molecular components of adrenergic stimulation 
β-adrenergic stimulation of IKs plays a critical role in cardiac electrical conduction by 
shortening action potential duration to accommodate elevated heart rates.  There have been 
considerable efforts to elucidate the molecular pathway for the β-adrenergic regulation of IKs.  In 
1988 it was shown that stimulation of protein kinase A (PKA) activity by a cAMP analog can 
upregulate the delayed rectifier current21.  Later, it was demonstrated that the scaffolding protein 
A-kinase anchoring protein 9 (AKAP-9), also known as yotiao, plays a central role in adrenergic 
regulation of IKs by compartmentalizing key elements of the PKA signaling pathway and 
allowing for spatiotemporal control.  AKAP-9 binds to the CTD of KCNQ1 and recruits 
signaling proteins including PKA, protein phosphatase 1 (PP1)154, adenylyl cyclase 9 (AC9)155, 
and the phosphodiesterase PDE4D3156 (Fig. I4 a).  Together these proteins form the IKs 
macromolecular complex that can tightly control the phosphorylation state of the channel in 
response to adrenergic stimulation.  PKA phosphorylates KCNQ1 at the S27 residue, adding a 
negatively charged phosphate group.  This modification leads to increased channel activation and 
slowed deactivation154,157 (Fig. I4 d).  In addition, phosphorylation of AKAP-9 itself contributes 
to the PKA-mediated upregulation of IKs158.  Taken together, these molecular components of 
mediate IKs response to β-adrenergic signaling, allowing for control of action potential that is 
critical to normal physiology and can become aberrant in disease. 
 
IKs loss-of-function in long QT syndrome 
Long QT syndrome (LQTS) is an arrhythmia characterized by a prolonged QT interval 
on EKG that leads to elevated risks of ventricular fibrillation and sudden cardiac death159.  In 
congenital LQTS, genetic mutations predominantly in cardiac ion channels prolong the cardiac 
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APD, which may trigger EAD’s and/or DAD’s and cause abnormal electrical activity in the heart 
as previously discussed.  There are 15 subtypes of congenital LQTS, each associated with 
mutations on a different gene160.  Among all LQTS subtypes, LQT1 is the most common, 
representing 30-35% of all congenital LQTS161.  Insight into the molecular mechanisms of 
disease mutations have greatly improved our understanding of LQTS pathophysiology and 
helped provide a first step to the future development of targeted therapies. 
Missense mutations in KCNQ1 are responsible for the majority of LQT1 cases and can 
cause channel loss-of-function through a variety of molecular mechanisms, including defects in 
ion permeation, channel gating, trafficking, KCNQ1-KCNE1 interaction, PKA-mediated 
signaling pathway, PIP2 binding and calmodulin binding2.  The mechanisms of mutations may 
bear implications on patient phenotype, severity of arrhythmia, as well as response to therapy.  
For example, one study showed that mutations in highly conserved KCNQ1 residues, such as 
those in the P-loop, which contains the selectivity filter, are associated with higher risks of 
cardiac events162,163.  These residues are likely conserved because they are critical to channel 
function.  Indeed, three LQT1 mutations near the selectivity filter, T322M, T322A, and G325R 
have been shown to abolish channel conductance163,164 and exert dominant negative effects.  
Another study showed that missense mutations in the cytoplasmic loops between S2-S3 and 
between S4-S5 are associated with an elevated risk of aborted cardiac arrest and sudden cardiac 
death165.  Four mutations in these cytoplasmic loops, G189R, R190Q, R243C, and V254M, all 
diminish IKs upregulation in response to forskolin and thus may render patients particularly 
susceptible to arrhythmic events under stressful conditions.  Understanding these mutation-




While the vast majority of LQTS mutations occur in KCNQ1, a number of disease 
mutations have also been found in KCNE1 and AKAP-9, which are classified as LQT5 and 
LQT11, respectively.  Co-assembly of KCNQ1 with KCNE1 is key to generating the IKs current.  
Thus it follows that KCNE1 mutations can alter the physiologically relevant current of the 
assembled channel and lead to LQTS.  As previously discussed, another protein that associates 
with KCNQ1 is AKAP-9, an important mediator of adrenergic signaling.  That a mutation in 
AKAP-9 can cause LQTS is a testament to the critical role of PKA signaling in the regulation of 
the IKs macromolecular complex166.  The S1570L mutation, located near the C-terminal binding 
domain of AKAP-9, disrupts interaction with KCNQ1, reduces cAMP-stimulated 
phosphorylation of KCNQ1, and abolishes IKs upregulation in response to cAMP.   
 
IKs gain-of-function in short QT syndrome and atrial fibrillation 
Whereas loss-of-function mutations in IKs subunits are associated with long QT 
syndrome, gain-of-function mutations in IKs are associated with short QT syndrome (SQTS) 
and/or atrial fibrillation.  Atrial fibrillation, the most common arrhythmia in the US, affects more 
than 3 million adults167 and is a major cause of morbidity and mortality.  In atrial fibrillation, 
abnormal electrical activity causes excessively rapid atrial contractions that hinder normal 
cardiac function.  Inherited forms of atrial fibrillation are associated with earlier onset of disease 
compared with typical forms168.  While they are much rarer, investigating their underlying 
mechanisms can provide insights on the pathophysiology and management of the much more 
prevalent forms of disease.  In addition, patients with short QT syndrome present with 
abnormally shortened QT interval on EKG and are at elevated risk of atrial fibrillation and 
sudden cardiac death169.  Both short QT syndrome and inherited forms of atrial fibrillation 
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predominantly result from ion channel mutations, such as in NaV1.5170, Kir2.1171, CaV1.2172, 
hERG173 and KCNQ1174,175. 
A number of atrial fibrillation mutations in KCNQ1 significantly slow the kinetics of IKs 
deactivation174-176.  Previous studies showed that deactivation slowing causes significant 
accumulation of IKs upon repeated stimulation and underlies β-adrenergic-induced shortening of 
APD177.  This pathway has been shown to also induce atrial arrhythmia in transgenic mice 
expressing IKs178, suggesting that while IKs normally contributes little to atrial action potential, 
gain-of-function in IKs can disrupt electrical activity.  Accumulation of IKs excessively shortens 
action potential duration as well as the refractory period of cardiac tissues, predisposing to re-
entry arrhythmia such as atrial fibrillation.  Given the central role of IKs deactivation slowing in 
arrhythmogenesis, investigating the gating alterations underlying deactivation slowing by 
KCNQ1 atrial fibrillation mutations can prove critically useful for designing mechanism-based 
therapies to restore channel function. 
 
Pharmacologic Activation of KCNQ1 and IKs 
Although the most common subtype of LQTS is associated with IKs loss-of-function, IKs 
is not yet a direct target in antiarrhythmic therapy.  However, conceptually, IKs activators could 
serve useful roles in therapy and provide a mechanism-based approach to rescuing channel loss-
of-function.  A number of small-molecules that activate IKs have been identified at the benchside 
and may guide future development of therapeutic agents.  For example, the compounds 4,4-
diisothiocyanatostilbene-2,2-disulfonic acid (DIDS) and mefenamic acid both increase IKs 
current amplitude179.  In addition, DIDS has been shown to drastically slow IKs deactivation.  
Another KCNQ1 activator, ML277, both increase KCNQ1 amplitude and slow current 
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deactivation.  Interestingly, its effect diminishes with progressive increase in KCNE1:KCNQ1 
stoichiometry180.  While a drug with such properties is not expected to directly serve therapeutic 
roles, understanding its mechanism of action can provide crucial insight on general mechanisms 
of channel gain-of-function and guide future efforts to modulate channel function.   
 
Focus of Investigation 
For both KCNQ1 atrial fibrillation mutations and molecular activators, slowing of 
deactivation plays a critical role in increasing channel function.  However, the underlying gating 
mechanism of slowing remains unknown and can shed light on channel function and modulation.  
Deactivation slowing can potentially result from slowing of voltage sensor movement, slowing 
of pore opening/closing, alteration of voltage sensor-pore coupling, or a combination of these 
gating processes in a voltage-dependent ion channel.  In this thesis, we examined the gating 
effects underlying deactivation slowing using voltage clamp fluorometry to assay for voltage 
sensor movement simultaneously with ionic current through the channel pore.  In addition, we 
utilized kinetic modeling to elucidate gating processes altered by mutations and molecular 
activators.  These studies provide fundamental insights on mechanisms of deactivation slowing 






RNA was prepared from DNA sequences in the pGEMHE vector after linearization with 
the restriction enzyme NheI and in vitro transcription using the mMESSAGE mMACHINE T7 
Transcription Kit from ThermoFisher.  For DNA sequences in the pSD64TF vector, the 
restriction enzyme SacI and mMESSAGE mMACHINE SP6 Transcription Kit were used. 
A cysteine site was 
engineered at residue G219 on 
the extracellular loop of KCNQ1 
between S3 and S4 that can be 
labelled with the fluorophore 
Alexa-488 maleimide (Fig. M1 
a) to monitor S4 conformational 
changes.  To enhance specificity 
of labelling, two native cysteine 
residues (214 and 331) predicted 
to be accessible to the 
extracellular environment were 
mutated to alanine.  This 
construct has been used in 
multiple VCF studies83,84,121,181 
and is here simply referred to as 
KCNQ1.  The terms 
Figure M1. The voltage clamp fluorometry (VCF) technique.  (a) In 
the KCNQ1 VCF construct, a cysteine residue is engineered at the S3-S4 
linker, where a fluorophore (shown in green) is covalently attached to 
monitor conformation changes in the S4 (red cylinder).  (b) The 
schematic of VCF illustrates a Xenopus laevis oocyte expressing KCNQ1 
labelled with fluorophore.  Ionic current is recorded using two-electrode 
voltage clamp while fluorescence is simultaneously measured by a 
photodiode.  (c) Example VCF recording of KCNQ1 under a single pulse 
protocol.  Current is shown in black while fluorescence is shown in red 
below.  The horizontal dashed line indicates zero current level.  Panels 
(a) and (b) from Jeremiah Osteen. 
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“KCNQ1S140G” and “KCNQ1V141M” denote KCNQ1 subunits containing mutations.  The terms 
“IKsS140G” and “IKsV141M” denote KCNQ1 mutants co-expressed with KCNE1.  The term wildtype 
(WT) refers to the original KCNQ1 construct without engineering for use in VCF. 
 
Oocyte Expression 
Defolliculated Xenopus laevis oocytes were supplied by Ecocyte Bioscience.  For 
KCNQ1 experiments, 50 ng of KCNQ1 RNA was injected into oocytes.  For IKs experiments, 33 
ng KCNQ1 and 10 ng KCNE1 were injected.  For KCNE1 experiments with mutant channels, 
total RNA injected was reduced, but the KCNQ1:KCNE1 RNA ratio was kept the same.  For 
PIP2 depletion experiments without KCNE1, 33 ng KCNQ1 and 17 ng ciVSP were injected.  For 
PIP2 depletion experiments with KCNE1, 23.5 ng KCNQ1, 7 ng KCNE1, and 14.7 ng ciVSP 
were injected, with the same KCNQ1:KCNE1 RNA ratio as previously.  In all IKs injections, the 
KCNE1:KCNQ1 RNA transcript ratio exceeds 1:1 and is expected to saturate the α-subunit148.  
Injection was performed using Nanoject II from Drummond. 
 
VCF 
VCF experiments were performed 2-5 d after injection.  Oocytes were labelled with 100 
µM Alexa-488 maleimide in ND96 (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 
mM HEPES, pH 7.5 with NaOH) for 30 min at 12 oC.  Following labelling, they were kept on 
ice to prevent internalization of labelled channels.  Oocytes were placed into a recording 
chamber with animal pole “up” in ND96 solution.  100 µM LaCl3 was used to block endogenous 
hyperpolarization-activated currents.  All recordings were performed at 22-24 oC using the TC-
324B temperature controller from Warner Instrument Co.  For UCL2077 experiments, 10 µM 
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UCL2077 was pipetted into the recording chamber.  For ML277 and R-L3 experiments, 10 µM 
ML277 or R-L3 was applied using the perfusion system.  0.1% DMSO was used in drug control 
experiments.   
Current was recorded using the two-electrode voltage clamp configuration with the 
Oocyte Clamp OC-725C amplifier (Warner Instrument Corp.).  Recording pipettes were pulled 
to a resistance of 0.7-1.5MΩ using the Model P-97 Flaming/Brown Micropipette puller (Sutter 
Instrument Co.) and filled with 3 M KCl.  Data were digitized with Digidata 1440A low-noise 
data acquisition system (Axon CNS Molecular Devices) and collected with Clampex 10 
software.  Fluorescence recordings were made using Olympus BX61WI upright microscope with 
Oregon Green filter set (41026 – Chroma).  Light was focused on the top of oocyte using a 20x 
water immersion objective.  Fluorescence signal was collected by a photodiode and amplified 
using Axopatch 200A amplifier (Axon Instruments).  The signal was subject to a 100Hz lowpass 
Bessel filter (Frequency Devices Inc.) before being digitized by the Digidata 1440A and 
collected by Clampex10.  See Figure M1 b for a diagram of the VCF setup.  By convention, 
current is represented in black and fluorescence is represented in red (Fig. M1 c).  Upward 
deflection of fluorescence signal represents S4 activation and downward deflection represents S4 
deactivation for KCNQ1 and IKs. 
Isochronal activation was measured for KCNQ1 alone using a protocol with holding 
potential at -80 mV, a 2-s prepulse to -140 mV to more fully deactivate voltage sensors, a 2-s test 
pulse ranging from +60 mV to -140 mV, a 2-s repolarizing pulse to -40 mV, and a sweep interval 
of 17 s.  For KCNQ1 in the presence of KCNE1, isochronal activation was measured using a 
protocol with a holding potential at -110 mV, a 3-s prepulse to -140 mV, a 5-s test pulse ranging 
from +80 mV to -160 mV, a 5-s repolarizing pulse to -40 mV, and a sweep interval of 23 s.  
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Negative holding potentials and prepulse were used to deactivate channels more fully.  To 
measure the effect of the small-molecule activator ML277 on KCNQ1 isochronal activation, a 
voltage protocol was used with holding at -80 mV, a 2-s test pulse ranging from -140 mV to +80 
mV, a 2-s repolarizing pulse to -120 mV, and a sweep interval of 15 s.  For experiments with the 
activator R-L3, a 2-s prepulse at -120 mV was introduced to close channels more completely. 
 
Rb+/K+ Permeability Ratio 
Two-electrode voltage clamp experiments were performed 2-5 d after injection.  Oocytes 
were recorded at room temperature (22-24 ºC).  Voltage protocol was applied with holding at -
110 mV, a 2-s prepulse at -120 mV, a 5-s pulse to +40 mV, followed by repolarization to -60 
mV.  Currents were recorded under either high external K+ (100 mM KCl, 1.8 mM CaCl2, 1 mM 
MgCl2, 5 mM HEPES, pH 7.5 with NaOH) or high external Rb+ (96 mM RbCl, 4 mM KCl, 1.8 
mM CaCl2, 1 mM MgCl2, 5 mM HEPES, pH 7.5 with NaOH). 100 µM LaCl3 was used to block 
endogenous hyperpolarization-activated currents.  Rb+/K+ permeability ratios were determined 
using inward tail current measured at -60 mV following the 5-s activation pulse at +40 mV.  
Inward tail currents were determined following normalization of outward current to calculate 
Rb+/K+ ratios.  These ratios were used to calculate the expected fraction of open channels in the 
intermediate voltage sensor state at the end of activation or IKsS140G and IKsV141M. 
 
Data Analysis 
Steady-state voltage-dependence of current was determined from exponential fits of tail 
currents at -40 mV following the test pulse.  Fits were extrapolated to beginning of tails to avoid 
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“hooks” that result from channel inactivation.  GV relationships were fitted with a Boltzmann 
equation: 
GV 	 	A2 	 A1  A2/1 	 expV  V//K 
 
where A1 and A2 are the minimum and maximum, respectively, V1/2 is the voltage at half-
maximal activation, and K is the slope.  Fluorescence was bleach-subtracted and averaged over 
tens of milliseconds at end of test pulse to reduce errors from signal noise.  Voltage-dependence 
of fluorescence (FV) was also fitted with the Boltzmann equation. 
Statistical data analysis was performed using two-tailed student’s t-test or one-way 
analysis of variance (ANOVA) with Tukey’s post-hoc test.  Differences at P < 0.05 were 
considered significant. 
 
Kinetic Modeling  
A Markov model of 
KCNQ1 and IKs gating was 
modified from previous studies to 
reflect more recently published 
results83,84.  In this scheme, voltage 
sensors can exist in resting, 
intermediate, or fully activated 
states84 (Fig. M2).  Voltage sensor 
movement is represented by 
horizontal transitions in the model 
Figure M2. Model schematic with rate parameters.  In this 
scheme, vertical transitions represent pore opening/closing, and 
horizontal transitions represent voltage sensor movement.  
Voltage sensor movement proceeds in two steps: first, 
independent activation of four voltage sensors into the 
intermediate state (red), followed by a concerted movement to the 
fully activated state (blue).   
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and occurs in two steps: first, independent movement of four identical voltage sensors to an 
intermediate state121; second, a concerted movement to a fully activated state83.  Channel 
opening/closing is represented by vertical transitions.  Channel opening can occur in every 
voltage sensor configuration but increases in probability with each step of voltage sensor 
activation.  Open states are assumed to have equal conductance.   
The total fluorescence signal is calculated with each voltage sensor contributing to ¼ of 
the fluorescence signal in the first step of activation.  The second, “concerted” step of activation 
accounts for another 14% of total fluorescence, based on our fitting results. 
Rate constants that govern voltage sensor transitions are voltage dependent and are 







where V is the membrane potential, V1/2 is the equilibrium potential for the forward-reverse 
process, F is Faraday’s constant (96485 C mol-1), R is the ideal gas constant (8.314 J mol-1 K-1), 
T is the temperature (K), and z and k1/2 are parameters for each rate constant.  At the equilibrium 
potential, k = k1/2. 
Channel pore opening and closing are assumed to be voltage-independent and are 
governed by the allosteric coupling factor L, which represents the degree of voltage sensor-pore 
coupling in the first step of voltage sensor activation.  Similarly, the coupling factor M represents 
degree of coupling in the second, concerted step of voltage sensor activation.   
The model satisfies microscopic reversibility, a thermodynamic principle that requires 
forward transition rates to equal reverse rates between any two states at thermodynamic 
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equilibrium183.  Microscopic reversibility also ensures that the total number of channels is 
conserved.  In order to satisfy microscopic reversibility, for any loop in the model, the product of 
rates in the clockwise direction equal the product of rates in the counterclockwise direction. 
The wildtype models for KCNQ1 and IKs contain 14 free parameters.  Parameters were 
fitted using the simulated annealing algorithm to identify a global minimum184.  The model was 
constrained using the following data: isochronal activation of conductance and fluorescence, 
kinetics of fluorescence and current activation and deactivation, and fluorescence deactivation 
following PIP2 depletion.  The KCNQ1S140G model contains 2 free parameters, while the IKsS140G 
and IKsV141M models contain 4 free parameters each.  Additionally, Rb+/K+ permeability ratios 
























Chapter 1: Gating mechanisms underlying deactivation slowing by atrial fibrillation 






KCNQ1 is a voltage-gated potassium channel that is modulated by the β-subunit KCNE1 
to generate IKs, the slow delayed rectifier potassium current, which plays a critical role in 
repolarizing the cardiac action potential.  Two KCNQ1 gain-of-function mutations, S140G and 
V141M, drastically slow IKs deactivation and cause a genetic form of atrial fibrillation.  
However, the underlying gating alterations remain unknown.  Voltage clamp fluorometry (VCF) 
allows simultaneous measurement of voltage sensor movement and ionic current through the 
channel pore.  Here, we use VCF and kinetic modeling to determine the effects of mutations on 
channel voltage-dependent gating in the absence of KCNE1.  We show that S140G directly 
slows voltage sensor movement, which indirectly slows current deactivation.  On the other hand, 
V141M has minimal effect on channel gating.  Our results are consistent with a previous 
homology model of KCNQ1 and provides the basis for future studies of gating mechanisms 
underlying IKs gain-of-function. 
 
Introduction 
KCNQ1 is the pore-forming α-subunit of a voltage-gated potassium channel that 
assembles with the β-subunit KCNE1 in the heart to generate the IKs current, which is critical for 
normal repolarization of the cardiac action potential31,32.  Mutations in IKs subunits are associated 
with potentially lethal arrhythmia, including long QT syndrome85,185, short QT syndrome186, and 
atrial fibrillation174.  Gain-of-function mutations in IKs subunits that cause atrial fibrillation 
increase the repolarizing current during repetitive stimulation and shorten the action potential 
duration187, which is thought to reduce the refractory period and predispose the heart to electrical 
re-entry.   
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Atrial fibrillation is the most common cardiac arrhythmia and affects more than 3 million 
adults in the United States167.  Much rarer, genetic forms of atrial fibrillation have been 
associated with gain-of-function mutations in potassium channel subunits, such as two adjacent 
mutations in KCNQ1, S140G174 and V141M175.  S140G was the first KCNQ1 mutation linked to 
atrial fibrillation.  It is inherited in an autosomal dominant pattern in a Chinese family174 and 
causes a gain-of-function IKs phenotype.  Later, a patient with atrial fibrillation and short QT 
syndrome was found to have a de novo missense mutation in KCNQ1.  The mutation, V141M, is 
adjacent to S140G and also causes IKs gain-of-function175.  While genetic forms of atrial 
fibrillation are very rare, they present an opportunity to study underlying mechanisms of IKs 
activation and modulation, which may pave the way for developing therapies for more common 
arrhythmia such as long QT syndrome and typical forms of atrial fibrillation. 
KCNQ1, the pore-forming subunit of IKs, contains a voltage-sensing domain (VSD) and a 
pore domain.  The VSD spans transmembrane helices S1-S4 and contains net positive charges on 
S4 that allow it to sense changes in membrane potential.  The pore domain spans S5-S6 and 
contains the selectivity filter that allows for K+ permeation.  The VSD is coupled to the pore 
domain through interactions between the S4-S5 linker and the C-terminus of S6 and requires the 
lipid molecule phosphatidylinositol 4,5-bisphosphate (PIP2)95,97,188.  While KCNQ1 is modulated 
by KCNE1 to generate the cardiac IKs current, KCNQ1 by itself is able to form a homotetrameric 
potassium channel that is capable of voltage-dependent gating. 
Both S140G and V141M are located at the extracellular end of the S1 helix of KCNQ1, 
which is part of the VSD.  While initially thought to cause constitutive activation of IKs, later 
studies using more negative voltage pulses showed that both mutations drastically slow IKs 
deactivation189,190, which can cause accumulation of open channels under repeated stimulation 
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and abnormally increase the repolarizing K+ current.  Interestingly, the impact of these mutations 
on channel deactivation kinetics displays distinct dependence on KCNE1.  Whereas S140G 
slows channel deactivation regardless of the presence of KCNE1, V141M only slows 
deactivation when KCNE1 is present.  This result is supported by a homology model of KCNQ1, 
in which S140 points toward a salt bridge interaction within the VSD, whereas V141 points away 
from the α-subunit and toward the putative location of KCNE1137.  Furthermore, cysteine 
crosslinking studies have shown that V141 crosslinks with residues on KCNE1, whereas S140 
does not190.  Nonetheless, the gating mechanisms underlying the slow deactivation conferred by 
these mutations remain unknown.  Understanding these gating mechanisms both in the absence 
and presence of KCNE1 can shed light on KCNQ1 function in addition to its modulation by 
KCNE1.  
In this study, we use VCF to examine the gating effects of these mutations on KCNQ1 in 
the absence of KCNE1 (KCNQ1S140G/ KCNQ1V141M).  We determine whether any slowing in 
current deactivation is caused by a slowing in voltage sensor deactivation.  We show that 
KCNQ1S140G slows both current and voltage sensor deactivation, and additionally causes a 
hyperpolarizing shift in the voltage-dependence of current and voltage sensor activation.  On the 
other hand, KCNQ1V141M has minimal effect on channel gating.  In order to dissect the effect of 
the mutation on channel voltage sensor from the pore, we utilized PIP2 depletion and UCL2077 
inhibition in two separate approaches.  Our results show that KCNQ1S140G slows voltage sensor 
deactivation independently of pore opening.  Furthermore, our kinetic models are consistent with 
KCNQ1S140G directly slowing voltage sensor deactivation, which indirectly slows current 
deactivation.  Simulations of current and fluorescence agree with our VCF data.  These findings 
not only shed light on voltage-dependent gating processes in KCNQ1, but provide an important 
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In the absence of KCNE1, S140G, but not V141M, alters voltage sensor movement and 
channel gating 
To study the gating effects of atrial fibrillation mutations using VCF, we employed a 
KCNQ1 construct containing a cysteine site at the extracellular residue G219 in the S3-S4 linker 
that can be labelled covalently with a fluorophore.  This construct had been used in multiple 
VCF studies83,84,121,181 to report S4 movement, and we refer to it here as KCNQ1.  We first used a 
Figure 1.1.  S140G, but not V141M, affects voltage sensor deactivation and left-shifts the isochronal 
activation in the absence of KCNE1.  (a-c) Current (black) and fluorescence (red) traces for KCNQ1 (a), 
KCNQ1S140G (b) , and KCNQ1V141M (c) using the following protocol: from a prepulse of -140 mV, a test pulse 
was applied at +60 mV, followed by a repolarizing step to -40 mV.  Cells were held at -80 mV. (d-f) 
Normalized isochronal (2 s) activation of fluorescence (red) and conductance (black) for KCNQ1 (d), 
KCNQ1S140G (e), and KCNQ1V141M (f).   
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single pulse protocol to determine whether the atrial fibrillation mutations S140G and V141M 
affect channel current and voltage sensor movement in the absence of KCNE1.  From a holding 
potential of -80 mV, a prepulse to -140 mV was applied to deactivate voltage sensors to the 
resting position.  Then, a single pulse to +60 mV was applied for 2 s followed by repolarization 
to -40 mV.  In comparison to KCNQ1, both KCNQ1S140G and KCNQ1V141M exhibit similar 
current and fluorescence activation kinetics at +60 mV (Fig. 1.1 a-c).  However, KCNQ1S140G 
appears to slow the deactivation kinetics of both current and fluorescence, whereas KCNQ1V141M 
does not appear to slow either.  To determine the voltage-dependence of activation, we applied 
the protocol at multiple voltages ranging from -140 mV to +60 mV and plotted the isochronal 
activation of fluorescence (FV) and conductance (GV) (Fig. 1.1 d-f).  Compared with KCNQ1 
(FV1/2 = -29.3 ± 2.5 mV, GV1/2 = -27.2 ± 3.3 mV), KCNQ1S140G (FV1/2 = -47.2 ± 2.1 mV, GV1/2 
= -44.8 ± 2.7 mV) causes a significant hyperpolarizing shift in in both FV and GV, whereas 
KCNQ1V141M (FV1/2 = -23.8 ± 1.3 mV, GV1/2 = -36.7 ± 2.0 mV) does not significantly shift 
either.   
 
In the absence of KCNE1, S140G slows voltage sensor and current deactivation, whereas 
V141M does not 
The primary pathological effect of these atrial fibrillation mutations is a slowing in 
current deactivation kinetics.  Therefore, in addition to previous single pulse measurements, we 
further examined deactivation by using a voltage protocol that first activates channels at +40 
mV, and then repolarizes to -100 mV in order to deactivate channels more completely.  Current 
and fluorescence were measured simultaneously and time to half deactivation during the -100-
mV pulse was determined as a marker of deactivation kinetics (Fig. 1.2).  Compared with 
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KCNQ1 (Ft1/2 = 232 ± 27 ms, It1/2 = 139 ± 17 ms), KCNQ1S140G (Ft1/2 = 1214 ± 27 ms, It1/2 = 550 
± 51 ms) significantly slows both fluorescence and current deactivation.  In contrast, 
KCNQ1V141M (Ft1/2 = 125 ± 11 ms, It1/2 = 156 ± 14 ms) slightly speeds fluorescence deactivation 
without affecting the current deactivation kinetics.   
 
S140G slows voltage sensor deactivation independently of channel opening in the absence 
of KCNE1 
Mechanisms other than a direct slowing in voltage sensor movement may result in an 
apparent slowing in voltage sensor deactivation.  For example, voltage sensor deactivation can 
be slowed indirectly by slowing of pore closing, since the pore is coupled to the voltage sensor.  
This concept of “retrograde coupling” has been previously illustrated by Zaydman et al. who 
showed that a pore mutation in KCNQ1 that stabilizes the open channel also stabilizes S4s in 
their activated states.  Upon depleting PIP2, which prevents channel opening (presumably by 
Figure 1.2.  In the absence of KCNE1, S140G slows both current and voltage sensor deactivation, whereas 
V141M slows neither.  From a prepulse of -140 mV, an activating pulse was applied at +40 mV, followed by a 
repolarizing step to -100 mV.  Channels were held at -80 mV.  (a) Normalized current during deactivation at -100 
mV for KCNQ1, KCNQ1S140G and KCNQ1V141M.  Inset shows first 2 s of deactivation.  (b) Normalized percent 
change in fluorescence during deactivation at -100 mV.  Inset shows first 2 s of deactivation. (c) Time to half 
deactivation (t1/2).  Data are shown as mean ± SEM (error bars).  *P<0.05; one-way ANOVA with Tukey’s test. 
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uncoupling the pore from the VSD), the effect on the S4s was abolished95.  As KCNQ1S140G 
slows voltage sensor movement and current deactivation by a similar order of magnitude, but 
with a slightly greater effect on the voltage sensor, we explored whether KCNQ1S140G slows 
voltage sensor movement when channel pore opening is prevented.  We focused on KCNQ1S140G 
over KCNQ1V141M, which has minimal effects on channel gating. 
Two approaches were used to 
test whether pore effects indirectly 
contribute to slowing of voltage 
sensor deactivation in KCNQ1S140G.  
In the first approach, either KCNQ1 
or KCNQ1S140G was co-expressed 
with the voltage-sensing phosphatase 
from Ciona intestinalis (ciVSP).  
Repeated depolarization activates 
ciVSP, which leads to depletion of 
PIP2 and thus prevents channel 
opening191.  When we first co-
expressed KCNQ1 with ciVSP and 
tested for current depletion, we found 
that repeated depolarizing pulses to +80 mV decrease channel tail current such that by the 12th 
pulse, only 7.1% ± 4.9% of the initial tail current remains (Fig. 1.3).  In contrast, amplitude of 
fluorescence change remains relatively constant during the time course of current depletion.  By 
the 12th pulse, 94% ± 5% of initial fluorescence remains, indicating intact S4 movement. 
Figure 1.3.  PIP2 depletion diminishes KCNQ1 current 
amplitude while voltage sensor movement remains intact.   
The voltage protocol involves depolarization to +80 mV and is 
repeated for 12 sweeps.  (a-b) Traces for sweeps 1, 2, and 12 are 
shown for current (black) and fluorescence (red).  (c-d) 
Normalized tail current and fluorescence change are plotted 
against sweep number. 
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To determine the effect of S140G on voltage sensor deactivation in the absence of pore 
effects, we applied a voltage protocol with an activating pulse to +40 mV followed by 
repolarization to -100 mV both before and after PIP2 depletion.  We observed a drastic decrease 
in current amplitude following PIP2 depletion in both KCNQ1 and KCNQ1S140G (Fig. 1.4 a-b), 
indicating a reduction of PIP2 levels in the plasma membrane.  We then determined the time to 
half deactivation for fluorescence at -100 mV (Fig. 1.4 c-e).  Before PIP2 depletion, KCNQ1S140G 
(Ft1/2 = 600 ± 46 ms) slows deactivation kinetics compared with KCNQ1 (Ft1/2 = 71 ± 10 ms), as 
expected.  Following PIP2 depletion, KCNQ1S140G (Ft1/2 = 966 ± 51 ms) still slows the 
fluorescence deactivation compared with KCNQ1 (Ft1/2 = 105 ± 13 ms).   
As a second approach to dissecting the voltage sensor effects of KCNQ1S140G from pore 
effects, we employed UCL2077, an inhibitor of IKs previously shown to prevent channel opening 
Figure 1.4.  In the absence of KCNE1, S140G slowing of voltage sensor deactivation is independent of 
channel opening based on PIP2 depletion.  The following protocol was used: from a prepulse of -140 mV, an 
activating pulse was applied at +40 mV, followed by a repolarizing step to -100 mV.  Channels were held at -80 
mV.  This protocol was used before and after PIP2 depletion by ciVSP, which was activated by repeated 
depolarization.  (a-b) Current before (+PIP2) and after PIP2 depletion (-PIP2) for KCNQ1 (a) and KCNQ1S140G (b).  
(c-d) Normalized fluorescence deactivation traces at -100 mV for KCNQ1 (red) and KCNQ1S140G (dark red) 
before (c) and after (d) PIP2 depletion.  (e) Time to half deactivation (t1/2) of fluorescence.  Data are shown as 
mean ± SEM (error bars).  *P<0.05; t-test 
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but still allow S4 movement83.  Application of 10 µM UCL2077 drastically reduces current of 
both KCNQ1 and KCNQ1S140G (Fig. 1.5 a-b).  When we analyzed the fluorescence deactivation, 
we found that both in the control condition and in the presence of 10 µM UCL2077, 
KCNQ1S140G significantly slows fluorescence deactivation (Control: Ft1/2 = 893 ± 59 ms; 
UCL2077: Ft1/2 = 602 ± 61 ms) compared with KCNQ1 (Control: Ft1/2 = 109 ± 23 ms; 
UCL2077: Ft1/2 = 109 ± 7 ms) (Fig. 1.5 c-e).  Taken together, the PIP2 depletion and UCL2007 
inhibition experiments show that KCNQ1S140G slows voltage sensor deactivation even in the 




Figure 1.5.  UCL2077 inhibition confirms that KCNQ1S140G slows voltage sensor deactivation independently 
of channel opening.  The following protocol was used: from a prepulse of -140 mV, an activating pulse was 
applied at +40 mV, followed by a repolarizing step to -100 mV.  Channels were held at -80 mV.  This protocol 
was used before and after inhibition of current with 10 µM UCL2077.  (a-b) Current before and after inhibition 
with UCL2077 for KCNQ1 (a) and KCNQ1S140G (b).  (c-d) Normalized fluorescence deactivation traces at -100 
mV for KCNQ1 (red) and KCNQ1S140G (dark red) in drug-free control (c) and in 10 µM UCL2077 (d).  (e) Time 
to half deactivation (t1/2) of fluorescence.  Data are shown as mean ± SEM (error bars).  *P<0.05; t-test 
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Kinetic modeling informs gating mechanisms for S140G in the absence of KCNE1  
To further elucidate the mechanism of S140G on KCNQ1 gating, we simulated current 
and fluorescence by modifying a previous Markov model of channel gating121, such that voltage 
sensors can exist in resting, intermediate, or fully activated states84 (Fig. 1.6 a).  Voltage sensor 
movement is represented by horizontal transitions in the model and occurs in two steps: first, 
independent movement of four S4’s to an intermediate state; second, a concerted step to a fully 
Figure 1.6.  Simulating the effects of S140G on KCNQ1 gating in the absence of KCNE1.  (a) Model of 
KCNQ1 gating.  In this model, KCNQ1 can exist in distinct channel states.  Horizontal transitions represent 
voltage sensor movement, while vertical transitions represent pore opening/closing.  Voltage sensors can exist in 
the resting (white), intermediate (red), or fully activated state (blue).  (b) Comparing experimental with simulated 
current (black) and fluorescence (red) traces for KCNQ1 and KCNQ1S140G.  (c) Descriptions of deactivation 
pathways at -100 mV for KCNQ1 and KCNQ1S140G based on model rates.  Arrows with greater opacity represent 
higher probability of channels entering the transitions specified.  In the absence of KCNE1, the probability of 
channels existing in fully activated voltage sensor states (transparent) is low.  The KCNQ1 channels can open and 
close in intermediate voltage sensor states during deactivation.  KCNQ1S140G slows voltage sensor deactivation, 
which causes increased channel openings and closings, as indicated by highlighting.  KCNQ1S140G thus indirectly 
slows current deactivation. 
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activated channel.  Channel opening probability increases with each step of voltage sensor 
activation.  
We obtained a model for KCNQ1 alone (Fig. 1.6 b, top) by fitting model parameters to 
our data for the kinetics and isochronal activation of both fluorescence and current.  We also 
simulated the effect of PIP2 depletion on fluorescence deactivation by preventing channel 
opening in the model, and then fitted these parameters to our VCF data.  The resulting current 
and fluorescence simulation under a single pulse protocol closely resembles our VCF data for 
KCNQ1.  Our model suggests that KCNQ1 deactivates through a pathway wherein channels may 
open and close when some or all voltage sensors are in intermediate states (Fig. 1.6 c, top).  As 
Figure 1.7.  Simulation of PIP2 depletion and isochronal activation for KCNQ1 and 
KCNQ1S140G.  (a) Normalized fluorescence deactivation at -100 mV before (left) and 
after (right) PIP2 depletion.  (b) Time to half deactivation of fluorescence.  PIP2 
depletion was simulated by slowing channel opening 10,000 times, effectively 
preventing channel opening.  (c) Normalized isochronal (2 s) activation for conductance 
(black) and fluorescence (red) for KCNQ1 and KCNQ1S140G.   
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voltage sensor deactivation proceeds, 
channels become less likely to open.  This 
leads to observed channel closure upon 
repolarization. 
After establishing a working 
KCNQ1 model, we next modeled 
KCNQ1S140G by altering only the voltage 
sensor transitions.  We found that by only 
altering two parameters that determine the 
rate and the midpoint of the first voltage 
sensor transition (Table S1), all effects of 
KCNQ1S140G are reproduced: a slowing in 
current and fluorescence deactivation (Fig. 1.6 b), and a hyperpolarizing shift in isochronal 
activation of conductance and fluorescence (Fig. 1.7).  Furthermore, in our model, the slowing of 
fluorescence deactivation in KCNQ1S140G is independent of channel opening (Fig. 1.7), 
consistent with our results from the PIP2 depletion and UCL2077 inhibition assays.  According 
to the model, directly slowing voltage sensor deactivation increases the number of times 
channels open when some or all voltage sensors are in intermediate states (Fig. 1.6 c, bottom).  
The increased number of openings indirectly slows current deactivation.  To test whether an 
alternative gating mechanism might also be consistent with the effects of KCNQ1S140G, we 
simulated channel current and fluorescence by only slowing pore transitions (Fig. 1.8).  This 
alteration slows current deactivation, but only slightly slows fluorescence deactivation, 
inconsistent with the VCF data.   
Figure 1.8.  Simulation of KCNQ1 pore slowing does 
not recapitulate the effects of S140G.  Fluorescence is 
shown in red whereas current is shown in black.  
Experimental and simulated traces are shown side by side 
for comparison.  According to the kinetic model, directly 
slowing pore slowing slows current deactivation but causes 
minimal voltage sensor slowing, inconsistent with the 





IKs deactivation slowing caused by 
two KCNQ1 atrial fibrillation mutations, 
S140G and V141M, is thought to play a 
key role in arrhythmogenesis by 
excessively increasing the repolarizing 
current during repetitive stimulation and 
shortening the action potential duration.  
Here, we have determined the gating 
alterations underlying slow deactivation by 
S140G in the absence KCNE1.  Using a combination of VCF and kinetic modeling, we showed 
that S140G slows current deactivation indirectly by altering voltage sensor movement.  
Conversely, a neighboring mutation that also causes atrial fibrillation, V141M, has minimal effect 
on channel gating.  These results are consistent with prior studies and a published homology model 
of KCNQ1, in which S140 faces toward the voltage-sensing S4 (Fig. 1.9) and is in proximity to a 
salt bridge interaction between R237 on S4 and E160 on S2 in the open state189,192.  We therefore 
propose that S140G stabilizes this interaction, thereby explaining the hyperpolarizing shift in the 
voltage-dependence of voltage sensor activation and slowing of voltage sensor deactivation.  In 
contrast, V141 points towards the lipids and away from the rest of the channel, thereby explaining 
the lack of effect on channel function by the mutation V141M.  
According to our kinetic model, two different gating alterations can slow current 
deactivation: either a direct slowing of pore transitions, or a direct slowing of voltage sensor 
Figure 1.9.  Homology model of KCNQ1.  This model of 
open tetrameric KCNQ1 and KCNE1 from Kang et al. 
(2008) shows the atrial fibrillation mutation sites from an 
extracellular view.  On the S1 helix, S140 (yellow) points 
toward S4, whereas V141 (blue) points away from the 
channel and toward the putative location of KCNE1.   
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movement which indirectly slows current deactivation.  A direct voltage sensor effect in 
KCNQ1S140G is supported by the good agreement between our simulation and our VCF data.  In 
addition, our PIP2 depletion and UCL2007 inhibition experiments revealed a direct voltage sensor 
effect independent of the pore.  Furthermore, our simulation of direct pore slowing is does not 
recapitulate the effects of KCNQ1S140G, further supporting current slowing as the indirect effect of 
voltage sensor slowing rather than a direct pore effect.  Thus, kinetic modeling guided our 
interpretation of the VCF data and elucidated the underlying gating alterations in KCNQ1S140G. 
While our results have elucidated the mechanism of current deactivation slowing for 
KCNQS140G, the gating alterations underlying deactivation slowing in the presence of KCNE1 
(IKsS140G and IKsV141M) remain to be determined.  Based on our present findings, one possible 
explanation is that IKsS140G and IKsV141M demonstrate distinct mechanisms of current slowing.  On 
one hand, IKsS140G may directly slow voltage sensor deactivation similar to KCNQ1S140G, 
indirectly slowing current deactivation.  This assumes that S140G’s gating effects are not altered 
by KCNE1.  However, previous measurements of current deactivation kinetics have shown that 
degree of slowing is greater in IKsS140G compared with KCNQ1S140G, suggesting that S140G’s 
effect may be partially dependent on KCNE1190.  Furthermore, the substitution of a serine 
residue with the much smaller amino acid glycine can cause structural changes beyond the 
locality of the residue, thereby altering the position of S1 and disrupting interaction with 
KCNE1.  On the other hand, given that V141M has minimal effect on KCNQ1 gating and that 
V141 crosslinks with residues on KCNE1, IKsV141M may slow deactivation by perturbing the 
orientation of KCNE1 relative to KCNQ1.  KCNE1 has been previously shown to play a critical 
role in modulating the coupling between the voltage sensor and the pore83,84.  It is therefore 
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possible that perturbing KCNE1 disrupts voltage sensor-pore coupling and contributes to 
deactivation slowing in IKsV141M.   
In summary, our VCF results and kinetic modeling elucidated the gating alteration 
underlying deactivation slowing in KCNQ1S140G.  We showed that KCNQ1S140G directly slows 
voltage sensor deactivation, which indirectly slows current deactivation.  On the other hand, 
KCNQ1V141M exerts minimal effects on channel gating.  These results are consistent with prior 
functional and structural data and form the basis for studying gating alterations by atrial 
















Chapter 2: Gating mechanisms underlying deactivation slowing by atrial fibrillation 








IKs, the slow delayed rectifier potassium current, is formed by the co-assembly of the 
pore-forming α-subunit KCNQ1 with the β-subunit KCNE1 and plays a critical role in 
repolarizing the cardiac action potential.  In Chapter 1 we studied the effects of two KCNQ1 
mutations associated atrial fibrillation, S140G and V141M, on KCNQ1 gating.  Here, we 
elucidate the gating mechanism underlying deactivation slowing in the presence of KCNE1 
(IKsS140G and IKsV141M), which contributes to the pathophysiology of atrial fibrillation.  We tested 
the hypothesis that IKsS140G, similar to KCNQ1S140G, slows voltage sensor deactivation and 
indirectly slows current deactivation, whereas IKsV141M disrupts voltage sensor-pore coupling.  
Using VCF and kinetic modeling, we found that both IKsS140G and IKsV141M alter voltage sensor-
pore coupling and slow pore closing, leading to slowing of IKs deactivation.  Our finding that the 
β-subunit modifies the gating effects of both mutations implicates novel molecular mechanisms 
through which KCNE1 modulates voltage sensor-pore coupling and pore motions. 
 
Introduction 
The pore-forming subunit KCNQ1 is modulated by the β-subunit KCNE1 to generate IKs, 
which plays a critical role in repolarizing the cardiac action potential.  Mutations in both subunits 
have been associated with potentially lethal arrhythmia including long QT syndrome, short QT 
syndrome, and atrial fibrillation.  Four subunits of KCNQ1 assemble to generate a voltage-
dependent ion channel with four voltage-sensing domains (VSDs) and a central pore.  Each 
voltage-sensing domain is composed of transmembrane helices S1-S4 and contains the positively 
charged S4 helix that responds to changes in membrane potential.  The channel pore is formed 
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by the pore domains (S5-P-loop-S6) of four KCNQ1 subunits.  Movement of the S4 is coupled to 
the pore through the S4-S5 linker and requires the presence of the lipid molecule PIP2.   
While KCNQ1 by itself can generate a voltage-dependent current, it is modulated by 
KCNE1 to generate IKs, characterized by a sigmoidal activation kinetics.  KCNE1 consists of a 
single transmembrane helix and is thought to have multiple and extensive points of contact with 
KCNQ1 that reside within both the VSD and the pore domain135-137,139-141.  The effects of 
KCNE1 on KCNQ1 function include a delay in the onset of activation, an increase in current 
amplitude, and a depolarizing shift in the current-voltage relationship31,32.  Voltage clamp 
fluorometry (VCF) experiments, which simultaneously measure voltage sensor movement and 
ionic current through the channel pore, have shown that KCNE1 alters the VSD-pore coupling in 
KCNQ1, delays the opening of the activation gate, and causes a hyperpolarizing shift in the 
voltage-dependence of the main voltage sensor activation and a depolarizing shift in the voltage-
dependence of current activation83,193.  The ratio of KCNE1 to KCNQ1 subunits in IKs remains 
controversial, with some evidence suggesting a fixed 2:4 ratio while others suggesting a 
flexibility in ratio that serves as a mechanism of channel regulation145-149. 
Deactivation slowing is thought to be the key pathophysiological mechanism by which 
two KCNQ1 mutations, S140G and V141M, cause a genetic form atrial fibrillation.  IKs 
deactivation slowing causes accumulation of open channels under repeated stimulation, which 
increases the repolarizing current in cardiomyocytes, shortens the action potential duration, and 
predisposes the heart to re-entry arrhythmia.  We have shown that in the absence of KCNE1, 
S140G slows voltage sensor deactivation, which indirectly slows current deactivation, whereas 
V141M has minimal effect on channel gating.  Based on these results, we hypothesized that 
deactivation slowing in the presence of KCNE1 may be due to different mechanisms between 
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S140G and V141M: IKsS140G may slow voltage sensor movement to indirectly slow current 
deactivation, whereas IKsV141M may perturb the orientation of KCNE1 relative to KCNQ1 to 
disrupt voltage sensor–pore coupling and slow deactivation.  However, without measurement of 
voltage sensor movement, the gating alterations underlying deactivation slowing in IKsS140G and 
IKsV141M remain unknown. 
Here, we use VCF and kinetic modeling to determine the gating effects of IKsS140G and 
IKsV141M.  We show that IKsS140G slows both current and voltage sensor deactivation, whereas 
IKsV141M slows current deactivation without slowing voltage sensor deactivation.  In contrast to 
KCNQ1S140G, voltage sensor slowing in IKsS140G is dependent on pore opening, suggesting that an 
alternative mechanism of slowing is present.  Interestingly, our kinetic models inform that both 
IKsS140G and IKsV141M alter VSD-pore coupling and slow pore closing, changing the pathway of 
deactivation such that channels in intermediate voltage sensor states can either reopen or stay 
open.  These findings provide key insights that aid the development of mechanism-based 
pharmacologic therapies for arrhythmias associated with IKs dysfunction. 
 
Results 
In the presence of KCNE1, S140G and V141M cause similar dysfunction in channel 
currents, but distinct effects on voltage sensor movement 
To understand the mechanisms underlying the effects of the atrial fibrillation mutations 
on the physiologic IKs current, we co-expressed KCNQ1 or KCNQ1 mutants with KCNE1 and 
used VCF to measure voltage sensor movement simultaneously with current.  As in previous 
studies, we utilized a KCNQ1 construct containing a G219C site in the S3-S4 linker that can be 
labelled covalently with a fluorophore to report voltage sensor movement.  Figure 2.1 a-c shows 
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currents and fluorescence changes measured in IKs and mutant channels in response to voltage 
pulses to +80 mV for 5 s followed by repolarization to -40 mV.  For IKs, fluorescence activation 
precedes current activation, as previously reported83.  Neither mutant channel appreciably affects 
the kinetics of current activation.  However, whereas IKs deactivates completely at -40 mV, 
neither IKsS140G nor IKsV141M deactivates appreciably.  Interestingly, IKsS140G and IKsV141M exert 
Figure 2.1.  In the presence of KCNE1, S140G slows current deactivation and voltage sensor movement 
whereas V141M slows current deactivation without slowing voltage sensor movement. (a-c) Current and 
fluorescence traces for IKs (a), IKsS140G (b), and IKsV141M (c) in the presence of KCNE1 using a single pulse 
protocol.  From a prepulse of -140 mV, a test pulse was applied at +80 mV followed by a repolarizing step to -40 
mV.  Cells were held at -110 mV.  Arrows indicate effect of mutations on current or fluorescence.  (d) 
Normalized current during deactivation at -100 mV for IKs, IKsS140G, and IKsV141M.  Inset shows the first 4 s of 
deactivation.  Deactivation was examined using the following voltage protocol: from a prepulse of -120 mV, an 
activating pulse was applied at +40 mV, followed by a repolarizing step to -100 mV.  Channels are held at -110 
mV.  (e) Normalized percent change in fluorescence during deactivation at -100 mV.  Inset shows first 4 s of 
deactivation.  (f) Time to 75% deactivation (t75%).  Data are shown as mean ± SEM (error bars).  *P<0.05; one-
way ANOVA with Tukey’s test. 
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distinct effects on voltage sensor movement.  IKsS140G apparently slows both the activation and 
deactivation kinetics of voltage sensor movement.  On the other hand, IKsV141M does not 
apparently alter voltage sensor kinetics, but leads to a different steady state level at -40 mV.  
Additional control experiments demonstrate that measured current for IKs, IKsS140G and IKsV141M 
are inhibited by 100 µM Chromanol 293B (Supplementary Fig. S1).  
As deactivation of mutant IKs is incomplete at -40 mV, we applied another voltage 
protocol in which we activated channels at +40 mV and then deactivated at -100 mV to close 
channels more fully.  We determined the time to 75% deactivation as a marker for deactivation 
kinetics (Fig. 2.1 d-f).  Compared with IKs (Ft75% = 2.74 ± 0.12 s, It75% = 0.307 ± 0.009 s), 
IKsS140G (Ft75% = 7.59 ± 2.06 s, It75% = 3.20 ± 0.23 s) significantly slows both voltage sensor and 
current deactivation by 2.8- and 10.4-fold, respectively.  IKsV141M (Ft75% = 1.59 ± 0.37 s, It75% = 
2.73 ± 0.18 s) also drastically slows current deactivation kinetics (8.9-fold), but does not slow 
voltage sensor deactivation.  The differing effects of the two mutations on voltage sensor 
movement suggest that they may slow current deactivation through distinct mechanisms in the 
presence of KCNE1.   
 
In the presence of KCNE1, both S140G and V141M alter isochronal activation of 
conductance and fluorescence 
Voltage-dependent activation curves illustrate the relationship between voltage sensor 
movement and pore opening and thus provide insight on voltage sensor-pore coupling.  Steady-
state measurement for IKs is difficult due to its very slow activation kinetics, and requires very 
long activating pulses that are not ideal for VCF experiments.  We therefore measured isochronal 
activation curves using 5-s pulses to study voltage-dependent activation of voltage sensors and 
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the pore.  When we plotted isochronal activation of fluorescence (FV) and conductance (GV) for 
IKs, we found that, as previously shown, KCNE1 divides voltage sensor activation into two 
components: a main component at hyperpolarized potentials where the channel remains closed, 
and a second component at depolarized potentials associated with channel opening (Fig. 2.2).  
For both IKsS140G and IKsV141M, there is a depolarizing shift in the main FV and a hyperpolarizing 
shift in the GV, leading to decreased separation between FV and GV.  The second component in 
the FV associated with channel opening is not discernable in both mutants and may overlap with 
the main component.  These results suggest that both IKsS140G and IKsV141M alter the relationship 
between voltage sensor and pore.  
 
In the presence of KCNE1, S140G slowing of voltage sensor deactivation is dependent on 
channel opening 
As previously discussed, direct effects on the channel pore may indirectly slow voltage 
sensor deactivation as the result of retrograde coupling.  We previously utilized PIP2 depletion 
and UCL2077 to prevent channel pore opening and dissect the voltage sensor effects of a 
mutation.  We showed in Chapter 1 that in the absence of KCNE1, S140G slows voltage sensor 
Figure 2.2.  Normalized isochronal (5 s) activation for fluorescence and conductance for IKs, IKsS140G, and 
IKsV141M.  Lines represent IKs for comparison.  Cells were held at -110 mV, prepulsed to -140 mV to deactivate 
channels, followed by test pulses between +80 mV and -160 mV in intervals of 20 mV.  Fluorescence is shown in 
red whereas conductance is shown in black. 
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deactivation independently of 
channel opening.  To investigate 
whether the same holds in the 
presence of KCNE1, we again used 
these two different approaches to 
prevent channel opening.  To first 
demonstrate the effect of PIP2 
depletion on current amplitude and 
voltage sensor activation in IKs, we 
co-expressed IKs with ciVSP and 
repeatedly depolarized the cell to 
+80 mV to activate the 
phosphatase.  Repeated 
depolarization reduces tail current 
amplitude, as shown in Figure 2.3.  However, the simultaneously measured fluorescence signal 
remains intact, indicating that voltage sensor movement is preserved as PIP2 is depleted.  
Furthermore, to verify the effect of UCL2077 on IKs gating, isochronal activation of IKs was 
recorded before and after application of 10 µM UCL2077.  As previously published, 10 µM 
UCL2077 effectively inhibits the IKs current (Supplementary Fig. S2), and at the same time 
reduces the second component of fluorescence that correlates with channel opening.  This is 
consistent with previous findings and suggest that UCL2077 does not simply block the channel 
pore, but stabilize the closed conformation of the channel.   
Figure 2.3.  PIP2 depletion diminishes IKs current amplitude 
while voltage sensor movement remains intact.  The voltage 
protocol involves depolarization to +80 mV and is repeated for 12 
sweeps.  (a-b) Traces for sweeps 1, 2, and 12 are shown for current 
(black) and fluorescence (red).  (c-d) Normalized tail current and 
fluorescence change are plotted against sweep number. 
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Given that IKsS140G, not IKsV141M, slows fluorescence deactivation, we focused our PIP2 
depletion and UCL2077 inhibition experiments on IKsS140G.  When IKs or IKsS140G was co-
expressed with ciVSP, activating ciVSP by repeated membrane depolarization resulted in a 
reduction of current amplitude in both channels, indicating a reduction in PIP2 (Fig. 2.4 a-b).  
Figure 2.4.  In the presence of KCNE1, S140G slowing of voltage sensor deactivation is dependent on 
channel opening.  The following protocol was used: from a prepulse of -140 mV, an activating pulse was applied 
at +40 mV, followed by a repolarizing step to -100 mV.  Channels were held at -110 mV.  (a-b)  Current 
measured before (+PIP2) and after PIP2 depletion (-PIP2) for IKs (a) and IKsS140G (b).  (c-d) Current measured in 
drug-free control and in 10 µM UCL2077 for IKs (c) and IKsS140G (d).  (e-f) Normalized fluorescence deactivation 
traces at -100 mV before (e) and after PIP2 depletion (f) for IKs (red) and IKsS140G (dark red).  (g) Time to 75% 
deactivation (t75%) of fluorescence before and after PIP2 depletion.  (h-i) Normalized fluorescence deactivation 
traces at -100 mV in drug-free control (h) and in 10 µM UCL2077 (i) for IKs (red) and IKsS140G (dark red).  (j) 
Time to 75% deactivation (t75%) of fluorescence in control and in 10 µM UCL2077.  Data are shown as mean ± 
SEM (error bars).  *P<0.05; one-way ANOVA with Tukey’s test (including IKsV141M). 
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Application of 10 µM UCL2077 also reduces current amplitude in both channels (Fig. 2.4 c-d).  
Fluorescence deactivation (Fig. 2.4 e-g) was simultaneously measured with current to show that, 
prior to PIP2 depletion, IKsS140G (Ft75% = 5.95 ± 0.88 s) significantly slows fluorescence 
deactivation compared with IKs (Ft75% = 3.10 ± 0.38 s).  However, surprisingly, following PIP2 
depletion, IKsS140G (Ft75% = 1.99 ± 0.21 s) no longer slows deactivation compared with IKs (Ft75% 
= 2.64 ± 0.22 s), contrary to what we observed in KCNQ1S140G.  Similarly, in drug-free 
conditions, IKsS140G (Ft75% = 6.06 ± 0.52 s) slows fluorescence deactivation compared with IKs 
(Ft75% = 3.90 ± 0.17 s); however, following current inhibition with 10 µM UCL2077, IKsS140G 
(Ft75% = 4.30 ± 0.34 s) no longer slows fluorescence deactivation (Ft75% = 5.36 ± 0.22 s) (Fig. 2.4 
h-j).  These results show that in the presence of KCNE1, S140G slowing of voltage sensor 
movement is dependent on channel opening. 
Although IKsV141M does not slow voltage sensor deactivation, we examined the effect of 
PIP2 depletion and UCL2077 inhibition on IKsV141M fluorescence deactivation as a control 
experiment.  Both activation of ciVSP as well as application of 10 µM UCL2077 reduced current 
amplitude (Fig. 2.5).  IKsV141M does not significantly alter fluorescence deactivation both before 
(Ft75% = 1.79 ± 0.17 s) and after PIP2 depletion (Ft75% = 2.26 ± 0.39 s).  Furthermore, IKsV141M 
does not significantly alter fluorescence deactivation kinetics in control conditions prior to 
application of 10 µM UCL2077 (Ft75% = 3.58 ± 0.39 s).  Following application of 10 µM 
UCL2077, IKsV141M speeds fluorescence deactivation 1.8 fold (Ft75% = 2.99 ± 0.31 s) compared 
with IKs.  However, this result was not observed in the PIP2 depletion experiment and thus may 





Figure 2.5.  Effect of IKsV141M on voltage sensor movement either under PIP2 depletion or UCL2077 
inhibition. The following protocol was used: from a prepulse of -140 mV, an activating pulse was applied at 
+40 mV, followed by a repolarizing step to -100 mV.  Channels were held at -110 mV.  (a-b) Current measured 
before (+PIP2) and after PIP2 depletion (-PIP2) for IKs (a) and IKsV141M (b).  (c-d) Current measured in drug-free 
control and in 10 µM UCL2077 for IKs (c) and IKsV141M (d).  (e-f) Normalized fluorescence deactivation traces at 
-100 mV before (e) and after PIP2 depletion (f) for IKs (red) and IKsV141M (orange).  (g) Time to 75% deactivation 
of fluorescence. (h-i) Normalized fluorescence deactivation traces at -100 mV in drug-free control (h) and 10 
µM UCL2077 (i) for IKs (red) and IKsV141M (orange).  (j) Time to 75% deactivation of fluorescence (right).  Data 
are shown as mean ± SEM (error bars).  *P<0.05; one-way ANOVA with Tukey’s test.    
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Kinetic modeling informs gating mechanisms for S140G and V141M in the presence of 
KCNE1 
We modeled the effects of S140G 
and V141M in the presence of KCNE1 
using the same gating scheme as 
described previously (Fig. 2.6 a).  This 
scheme describes three possible states for 
voltage sensors: resting, intermediate, and 
activated.  Horizontal transitions represent 
voltage sensor movement while vertical 
transitions represent pore opening/closing.  
We first modeled IKs by fitting parameters 
to our VCF data, including isochronal 
activation, activation kinetics, as well as 
deactivation kinetics for both current and 
fluorescence (Fig. 2.6 b top).  Our model 
simulations of IKs show good agreement 
with previous VCF recordings by Barro-
Soria et al. (Supplementary Fig. S3).  
Given that KCNQ1S140G directly 
slows voltage sensor movement, we first 
explored whether a direct voltage sensor slowing can also account for the effects of IKsS140G on 
fluorescence and current deactivation.  When we only slowed voltage sensor transitions in our 
Figure 2.6.  Simulation of IKs voltage sensor movement 
slowing does not recapitulate the effects of S140G.   
(a) Model of KCNQ1 gating.  In this model, horizontal 
transitions represent voltage sensor movement, while 
vertical transitions represent pore opening/closing.  Voltage 
sensors can exist in the resting (white), intermediate (red), 
or fully activated state (blue).  (b) According to the kinetic 
model, slowing only voltage sensor movement causes 
minimal slowing in current deactivation, inconsistent with 
the observed effects of IKsS140G (arrows). Fluorescence is 
shown in red and current is shown in black.  Experimental 
and simulated traces are shown side by side for 
comparison.   
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kinetic model of IKs, we found that, as expected, fluorescence deactivation slowed (Fig. 2.6 b 
bottom).  However, there was minimal slowing of current deactivation in our model, inconsistent 
with the observed effects of IKsS140G.  This result suggests that, unlike KCNQ1S140G, the slowing 
of current deactivation in IKsS140G cannot be explained by a direct voltage sensor slowing.  
Next, we modeled the effects of IKsS140G and IKsV141M by varying 4 parameters in the IKs 
model, with most changes occurring in the rate of the pore closing transition and a factor that 
controls voltage sensor-pore coupling (Table S2).  As before, model parameters were fitted to 
our experimental data on activation/deactivation kinetics, isochronal activation, and PIP2 
depletion.  To further constrain the model, we determined the Rb+/K+ permeability ratios of IKs 
and mutant channels.  It has been previously shown that the Rb+/K+ permeability ratio in 
KCNQ1 and IKs depends on the degree of voltage sensor activation84.  Specifically, channels in 
the intermediate voltage sensor state have a higher Rb+/K+ permeability ratio than channels in the 
fully activated voltage sensor state.  This allows us to estimate the fraction of ion channels in the 
Figure 2.7.  Using Rb+/K+ permeability ratios to constrain kinetic models of IKs mutants.  (a) Comparison of 
measured tail Rb+/K+ ratio with fraction of open channels in the intermediate VSD state following activation, as 
calculated from model after constraining.  Rb+/K+ permeability ratio was determined from inward tail current 
measured either under high external K+ or Rb+ concentration.  The ratios were converted to expected fraction of 
open channels in the intermediate VSD state and then used to constrain the model.  Results for KCNQ1 and IKs 
were used for normalization.  Data are shown as mean ± SEM (error bars).  *P<0.05; one-way ANOVA with 
Tukey’s test. (b) Averaged current recordings under high external K+ or Rb+ concentration. 
67 
 
intermediate voltage sensors state, which helps further constrain the model.  We determined the 
Rb+/K+ permeability ratios using inward tail current measured at -60 mV following a 5-s 
activation pulse to +40 mV.  The Rb+/K+ ratio of KCNQ1 (1.41 ± 0.14) is significantly greater 
than that of IKs (0.92 ± 0.06), suggesting that a greater fraction of open channels exists in the 
intermediate voltage sensor state for KCNQ1 compared with IKs (Fig. 2.7).  This is supported by 
a control experiment using the true wildtype KCNQ1 (Supplementary Fig. S4).  As for the IKs 
mutations, the Rb+/K+ ratio of IKsS140G (1.14 ± 0.08) is between that of KCNQ1 and IKs, whereas 
the ratio of IKsV141M (0.94 ± 0.07) is similar to IKs (Fig. 2.7).  Using these ratios, we calculated the 
expected fraction of open channels in the intermediate voltage sensor state following the 
activation pulse, and fitted our model of IKsS140G and IKsV141M to these results.   
Our resulting model simulates the distinct effects of S140G and V141M on current and 
fluorescence kinetics in the presence of KCNE1.  In our model, IKsS140G slows fluorescence and 
current deactivation, whereas IKsV141M slows current deactivation without slowing fluorescence 
deactivation (Fig. 2.9 a).  These effects are consistent with our experimental data.  Furthermore, 
the model is in agreement with our data on the effects of the two mutations on isochronal 
activation and fluorescence deactivation under PIP2 depletion (Fig. 2.8).  Specifically, IKsS140G 
slowing of fluorescence deactivation is dependent on pore opening, whereas IKsV141M has 
minimal effects on fluorescence deactivation regardless of whether pore opening is allowed. 
We calculated transition rates in our kinetic models at -100 mV for IKs, IKsS140G and 
IKsV141M to determine the pathway of channel deactivation (Fig. 2.9 b).  Our model of IKs shows 
that, as previously established, KCNE1 alters the coupling between the VSD and the pore in 
KCNQ1, preventing channel opening when voltage sensors are in the intermediate state84.  As a 






Figure 2.8.  Simulating PIP2 depletion and isochronal activation for IKs and mutants.  (a-f) Simulated 
normalized fluorescence deactivation traces before (a,d) and after PIP2 depletion (b,e), and time to 75% 
deactivation of fluorescence for IKsS140G (c) and IKsV141M (f).  PIP2 depletion was simulated by slowing channel 
opening 10,000 times, effectively preventing channel opening.  (g-h) Normalized isochronal (5 s) activation for 
conductance (black) and fluorescence (red) for IKsS140G (g) and IKsV141M (h).  Lines represent IKs for comparison. 
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deactivation.  IKsS140G alters the pathway of deactivation, such that channels are allowed to 
reopen in the intermediate voltage sensor states.  Interestingly, reopenings delay voltage sensor 
transitions to indirectly slow voltage sensor deactivation.  This is the opposite result from 
KCNQ1S140G, where voltage sensor slowing indirectly slows current deactivation.  Our model 
shows that IKsV141M deactivates through yet a different pathway, where most voltage sensor 
deactivation occurs prior to pore closing.  Despite their contrasting deactivation pathways, 
IKsS140G and IKsV141M share similarities in their gating effects as recapitulated in our models.  Both 
IKsS140G and IKsV141M alter VSD-pore coupling, such that channels in intermediate voltage sensor 
states are allowed to reopen or remain open.  In addition, our models are consistent with both 
IKsS140G and IKsV141M slowing the pore closing transition.  
 
Discussion 
KCNE1 modulates multiple biophysical properties of KCNQ1, including voltage-
dependent gating, to generate the cardiac IKs current.  Our findings show that in the presence of 
KCNE1, the two atrial fibrillation mutations slow current deactivation by altering the gating 
pathway of deactivation.  IKsS140G slows current deactivation by causing channels to reopen 
during early steps of voltage sensor deactivation.  These reopenings delay voltage sensor 
transitions and indirectly slows voltage sensor deactivation.  This is consistent with PIP2-
dependent slowing of fluorescence deactivation, because PIP2 depletion prevents channel 
opening and therefore removes the reopenings that delay deactivation.  IKsV141M alters the 
pathway of deactivation yet differently, such that the pore closes after most or all voltage sensors 
have deactivated.  These two distinct pathways of channel deactivation are consistent with our 
VCF results and contribute to slowing of current deactivation in the presence of KCNE1.   
70 
 
While IKsS140G and IKsV141M lead to different pathways of deactivation, they share two 
important similarities in their effects on channel gating.  First, both mutations alter VSD-pore 
coupling.  It has been previously shown that KCNQ1 alone is able to open with intermediate 
voltage sensor activation121 and that the addition of the β-subunit KCNE1 results in a channel 
that mostly opens after full voltage sensor activation.  Our experiments and models show that 
both IKsS140G and IKsV141M increase the open probability of channels in the intermediate voltage 
Figure 2.9.  Simulating the gating effects of S140G and V141M in the presence of KCNE1.  (a) 
Comparing experimental with simulated current (black) and fluorescence (red) traces for IKs (top), IKsS140G 
(middle), and IKsV141M (bottom).  (b) Description of deactivation pathways at -100 mV based on model rates.  
Arrows with greater opacity represent higher probability of channels entering the transitions specified.  States 
that channels rarely or never enter are grayed out.  Highlighting illustrates the most probable pathway of 
channel deactivation based on rates at -100 mV, starting from the fully activated open state.  IKs channels 
opens and closes only when voltage sensors are fully activated (top).  IKsS140G alters VSD-pore coupling and 
slows pore closing, altering the deactivation pathway such that during early steps of voltage sensor 
deactivation, channels may repeatedly open and close several times (middle).  Like IKsS140G, IKsV141M also 
alters VSD-pore coupling to allow channel opening in intermediate VSD states (bottom).  In addition, IKsV141M 
slows pore closing.  However, the deactivation pathway is different from IKsS140G in that voltage sensors 
deactivate to a greater extent prior to pore closing.   
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sensor states.  We propose that the mutations S140G and V141M partially reverse the KCNE1-
induced change in VSD-pore coupling, thereby allowing channels to open when the voltage 
sensors are in intermediate states such as in the case of KCNQ1 alone.  A second similarity 
between IKsS140G and IKsV141M is a slowing of the pore closing transition.  This may be surprising 
because both S140G and V141M are located near the extracellular end of the S1 helix, which is 
part of the VSD.  However, prior crosslinking studies have shown that the extracellular end of 
the KCNE1 transmembrane helix is in close proximity to both S1 and S6 of KCNQ1135,139.  
Furthermore, the homology model of the KCNQ1-KCNE1 complex from Kang et al. shows 
KCNE1 at a position between the S1 and the S6 of two different KCNQ1 subunits137 (Fig. 2.10, 
a).  Functional studies have shown that crosslinking K41 on KCNE1 with I145 on KCNQ1, 
roughly one turn above V141 on the S1 helix, slows current deactivation ~5-fold at -40 mV135.  
Crosslinking L42 on KCNE1 with V324 on the S6 of KCNQ1 results in extremely slow 
deactivation135.  These results suggest that the extracellular end of the S1 helix may interact with 
KCNE1 to indirectly modulate the S6 helix and influence gate motions.  We propose that in the 
presence of KCNE1, both S140G and V141M slow pore closing through these molecular 
interactions (Fig. 2.10, b).  Mutation at V141, a position which also has been shown to crosslink 
with KCNE1190, may directly disrupt the orientation of KCNE1 relative to the S6, restricting 
molecular motions involved in pore closing.  Mutation at S140, which faces toward the VSD of 
KCNQ1 and does not crosslink with KCNE1190, may perturb KCNE1 indirectly through its 
neighboring residue V141.  Although the homology model suggests that S140G should still 
directly slow voltage sensor deactivation in the presence of KCNE1, it is important to note that 
KCNE1 itself slows voltage sensor deactivation in our data.  If KCNE1 and S140G slow voltage 
sensor deactivation through a common molecular pathway, no additional effect on VSD 
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deactivation by S140G would be observed in the presence of KCNE1.  The possibility of 
KCNE1 mediating an indirect interaction between S1 and S6, which are part of the VSD and 
Figure 2.10.  Proposed molecular mechanisms underlying the effects of S140G and V141M on channel 
gating.  (a) Homology model of open tetrameric KCNQ1 and KCNE1 from Kang et al. (2008) from a side view 
(a).  On the S1 helix, S140 (yellow) points toward S4, whereas V141 (blue) points toward KCNE1.  The 
extracellular end of the S6 helix is in proximity to KCNE1.  (b) Cartoon representation of proposed molecular 
mechanisms of S140G and V141M.  The channel pore is represented by a cylinder with the K+ permeation 
pathway at its center.  For KCNQ1 alone (top row), V141M has minimal effect on channel gating, whereas 
S140G disrupts S4 and slows its movement.  In the presence of KCNE1 (bottom row), both V141M and S140G 
alter VSD-pore coupling and slow pore closing.  V141M may directly disrupt the orientation of KCNE1, 
impairing motion of the S6 during channel closing.  S140G may cause a similar disruption of KCNE1 indirectly 
through other residues on S1 that face KCNE1. 
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pore domain respectively, may explain how S140G and V141M alter VSD-pore coupling only in 
the presence of KCNE1.  In addition, there are pharmacologic activators of IKs whose functions 
depend on the presence of KCNE1194.  This together with our findings are consistent with the 
central role of KCNE1 in modulating KCNQ1 gating. 
In modeling the gating effects of IKsS140G and IKsV141M we attempted varying different 
permutations of parameters that might alternatively explain our VCF data, but they produced 
worse fit of the data compared to our final model.  For example, we found that a simpler model 
where pore deactivation is slowed without altering voltage sensor-pore coupling pore gave very 
poor fits of isochronal activation for both mutants.  Another simple model where coupling is 
altered without slowing pore deactivation does not fit the constraints imposed by Rb+/K+ 
permeability ratios.  These attempts suggest that both pore slowing and coupling alterations are 
required to explain the effects of the IKs mutants. 
One limitation in our study is that, because IKsS140G and IKsV141M deactivate very slowly, 
current accumulation occurred between sweeps of the isochronal activation experiment.  This 
accumulation likely caused an artefactual left-shift in the GV.  However, we found that 
recordings of IKsS140G and IKsV141M with minimal accumulation still showed a left-shifted GV 
compared with IKs.  In addition, in simulating the GV curve, our kinetic model takes into account 
possible current accumulation by utilizing the same isochronal activation protocol (including 
sweep duration) as our experiment.  A left-shifted GV curve is also seen in our model, although 
not to the extent seen experimentally.  A second limitation is that our oocyte experiments were 
performed at 22-24℃, where channel kinetics are slower than in the human heart (37℃).  
Nonetheless, when corrected for temperature-dependence based on prior measurements of Q10 
(2.58)195, the slowly deactivating mutant IKs is expected to also accumulate at physiological 
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temperatures.  Thus, the gating mechanisms underlying slow deactivation in our study hold 
physiological significance. 
In conclusion, the VCF studies presented here provide insight on the gating mechanisms 
involved in the slowing of current deactivation by two atrial fibrillation mutations, S140G and 
V141M.  The slow current deactivation in both IKsS140G and IKsV141M is mainly due to their effects 
on the voltage sensor-pore coupling and the pore closing transition.  This finding is particularly 
novel, because IKsS140G was previously assumed to slow current deactivation primarily by 
affecting the voltage sensor, similar to KCNQ1S140G.  In addition, our study suggests that KCNE1 
plays a central role in mediating the slow deactivation by both mutations.  As such, future efforts 
to identify molecular activators and inhibitors of IKs can benefit from targeting the β-subunit and 
inter-subunit interactions to alter physiologically relevant channel function.  These modulators 
may lead to mechanism-based pharmacologic agents and optimize therapy for arrhythmia 

























IKs is generated by the co-assembly of the pore-forming α-subunit KCNQ1 with the 
accessory β-subunit KCNE1 and plays a critical role in cardiac impulse conduction by 
repolarizing the cardiac action potential.  In Chapter 1 and Chapter 2 we explored the gating 
effects of two KCNQ1 atrial fibrillation mutations, S140G and V141M, both of which drastically 
slow IKs deactivation.  Many molecular activators of KCNQ1 and IKs both increase current 
amplitude and slow deactivation as well.  Two KCNQ1 activators, ML277 and R-L3, have been 
previously shown to slow current deactivation, but the underlying gating alterations remain 
known.  We utilized VCF and kinetic modeling to show that ML277 and R-L3 have distinct 
mechanisms of effect on KCNQ1 gating.  Whereas ML277 slows current deactivation with small 
effects on voltage sensor deactivation, R-L3 slows voltage sensor deactivation with smaller 
effects on current deactivation.  Kinetic modeling can account for the effects of ML277 by 
directly slowing channel pore transitions, while R-L3’s effects are recapitulated with a slowing 
of voltage sensor deactivation, which indirectly slows current deactivation.  These results 
demonstrate that different molecular activators achieve channel gain-of-function through distinct 
mechanisms, thereby providing a key step toward developing mechanism-specific modulators of 
channel function as therapy for arrhythmia. 
 
Introduction 
KCNQ1 is the pore-forming α-subunit that co-assembles with the β-subunit KCNE1 to 
generate IKs, which repolarizes the cardiac action potential and is critically important to normal 
cardiac impulse conduction.  Loss-of-function mutations in IKs may excessively prolong the 
action potential duration and cause long QT syndrome type 1, which predisposes patients to life-
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threatening arrhythmia such as torsades de pointes.  An existing problem in the clinical 
management of arrhythmia is that most antiarrhythmic medications do not target specific ion 
channels or gating mechanisms and cause undesired side effects such as additional 
arrhythmia196,197.  There is a need to develop mechanism-based therapies to optimize treatment 
and reduce side effects.  Understanding how IKs loss-of-function can be rescued by IKs activators 
in LQTS may offer a paradigm for future drug design. 
Although IKs activators are not currently used in clinical treatment of long QT syndrome,  
a number of molecular activators of IKs have been discovered34 and may guide the development 
of mechanism-specific therapeutics.  In addition, a number of activators increase KCNQ1 
function but not the physiologically relevant channel formed in association with KCNE1.  
Although these modulators are unlikely to be clinically useful, investigating the mechanisms 
underlying their effects may provide fundamental insights on how channel function can be 
increased.  Furthermore, different KCNQ1 activators may target distinct gating components of 
IKs, providing a basis for developing mechanism-based therapies. 
While the cardiac IKs current is generated by the co-assembly of KCNQ1 with KCNE1, 
four subunits of KCNQ1 can come together in the absence of KCNE1 to form an ion channel 
capable of voltage-dependent gating.  The channel consists of four voltage-sensing domains 
(VSD) and a central pore.  The S4 transmembrane helix of each VSD contains positive charges 
that allow the S4 to move in response to changes in membrane potential.  S4 movement is, in 
turn, coupled to the channel pore through the S4-S5 linker in the presence of PIP2, leading to 
opening/closing of the pore.  Each of these individual channel components can potentially be 
modulated by small molecules to alter channel function. 
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ML277 has been previously identified as a specific and potent activator of KCNQ1 (EC50 
= 0.26 µM in CHO cells)198.  It is selective against NaV1.5, CaV1.2, hERG, as well as other 
isoforms of KCNQ, including KCNQ2 and KCNQ4180,198.  ML277 not only increases KCNQ1 
current amplitude, but also slows current activation and deactivation.  Deactivation slowing has 
been previously shown to be a critical mechanism by which atrial fibrillation mutations as well 
as adrenergic stimulation cause accumulation of IKs in the context of repeated stimulation in the 
heart, thereby shortening the action potential.  Nonetheless, gating mechanisms underlying 
ML277’s slowing of deactivation remains unknown.  An additional property of ML277 is that 
progressive increase in KCNE1:KCNQ1 stoichiometry reduces the effect of ML2772.  According 
to molecular dynamic simulations, ML277 binds to a pocket in KCNQ1 that’s adjacent to the 
VSD, the pore domain, and the S4-S5 linker199.  Previous mutagenesis experiments further 
suggest that ML277 binds to the S4-S5 linker and the pore domain (Fig. 3.1).  It is possible that 
the presence of KCNE1 occludes the binding site of ML277.  
Similar to ML277, the benzodiazepine derivative R-L3 both increases current amplitude 
and slows current deactivation of KCNQ1200.  R-L3 selectively activates KCNQ1 over other 
currents, including the L-
type Ca2+ current as well as 
IKr200.  However, R-L3 does 
not activate IKs at a 
saturating KCNE1:KCNQ1 
ratio200.  Mutations of 
channel pore residues can 
drastically reduce R-L3’s 
Figure 3.1.  Potential binding sites for ML277 and R-L3 in KCNQ1 based 
on previous mutagenesis studies.  The locations of mutations that drastically 
reduce drug effects on current amplitude are shown.  Transmembrane helices 
that are part of the voltage sensing domain and the pore domain are shown in 
red and grey, respectively. 
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effect, suggesting that R-L3 binds to the pore (Fig. 3.1).  However, R-L3’s effect on the VSD has 
not been tested.  Furthermore, without functional data, gating mechanisms underlying R-L3’s 
effects, in particular it’s slowing of deactivation, remain unknown. 
Here, we use mutagenesis, VCF, and kinetic modeling to show that ML277 and R-L3 
cause distinct alterations of KCNQ1 gating.  Our chimera study shows that the pore domain of 
KCNQ1 endows channel activation by ML277.  VCF results show that ML277 slows current 
deactivation with a smaller slowing of fluorescence deactivation.  In addition, ML277 does not 
shift the voltage-dependence of activation for both conductance (GV) and fluorescence (FV).  In 
contrast, R-L3 drastically slows fluorescence deactivation with a smaller slowing in current 
deactivation, and it causes a hyperpolarizing shift in both the FV and GV.  Kinetic modeling 
suggests that ML277 directly slows pore opening and closing, whereas R-L3 slows voltage 
sensor deactivation, which indirectly slows current deactivation.  These results shed light on 
different mechanisms leading to slowing of deactivation by molecular activators, thus providing 
a key step toward future investigation of mechanism-based rescue of channel mutations. 
 
Results 
The KCNQ1 pore domain endows channel activation by ML277 
To determine whether ML277 activates KCNQ1 by acting on the pore domain, we take 
advantage of the fact that ML277 activates KCNQ1 but has minimal effect on the closely related 
KCNQ2.  To measure current, we used a single pulse voltage protocol consisting of a holding 
potential at -80 mV, a 2-s test pulse to +60 mV, followed by a repolarizing pulse to -120 mV.  
For WT KCNQ1, application of 10 µM significantly increases amplitude (194 ± 19%) and 
slowed the time constant of current deactivation (367 ± 64%) (Fig. 3.2).  However, for WT 
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KCNQ2, ML277 only increases amplitude by 19 ± 4% and slows deactivation by 10 ± 11%.  We 
then tested the ability of ML277 to activate a KCNQ1-KCNQ2 chimera.  The chimera is KCNQ2 
except for the pore domain (S5, S6, and P-loop between S5 and S6), which is from WT KCNQ1.  
We observed that 10 µM ML277 both increases the current amplitude by 195 ± 14% and slows 
current deactivation by 567 ± 105% for the chimera.  The degree of activation and slowing is 
similar to wildtype, demonstrating that the pore domain of KCNQ1 endows response to ML277. 
 
Figure 3.2.  The pore domain endows KCNQ1 response to ML277.  The effect of ML277 was tested in WT 
KCNQ1, WT KCNQ2, and a chimera that is KCNQ2 except for its pore domain (S5-P-S6), which is from WT 
KCNQ1.  Cells were held at -80 mV, depolarized to +20 mV for 2 s, and repolarized to -120 mV.  Current was 
recorded in control condition (black) and following addition of 10 µM ML277 (red).  Horizontal scale bar 
represents 1s, and vertical scale bars represent 1µA.  The percent increase in current amplitude and in time of 
half deactivation are summarized at the bottom.  Data are shown as mean ± SEM (error bars).  *P<0.05; one-
way ANOVA with Tukey’s test.  Figure adapted from Lei Chen. 
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ML277 slows current deactivation with smaller effects on voltage sensor deactivation 
To determine the effects of ML277 on channel gating, we utilized VCF to simultaneously 
measure current and fluorescence.  As in our previous studies, we used a KCNQ1 construct 
containing a cysteine site at the residue G219 in the S3-S4 linker that can be labelled with a 
fluorophore to report S4 movement.  We refer to the construct here as KCNQ1.  Using the same 
single pulse protocol as previously, we found that application of 10 µM ML277 significantly 
Figure 3.3.  ML277 has minimal effect on the voltage sensor movement of KCNQ1.  (a-b) Current (a) and 
normalized fluorescence (b) traces of KCNQ1.  Cells were held at -80 mV, depolarized to +20 mV for 2 s, and 
repolarized to -120 mV for 2 s to record tail currents.  (c) Comparing effect of ML277 on current and 
fluorescence deactivation kinetics time constant (tau) at -120 mV.  Data are shown as mean ± SEM (error bars). 
*P<0.05; paired t-test.  (d-e) Normalized isochronal activation curves for conductance (d) and fluorescence (e). 
Lines represent fits of data.  Error bars represent SEM.  In the isochronal activation protocol, cells were held at 
-80 mV, stepped between -140 mV and +80 mV for 2 s, followed by a pulse to -120 mV for 2 s.   
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increases the current amplitude of KCNQ1 by 95 ± 8% (Fig. 3.3).  ML277 also increases the 
current deactivation time constant by 289 ± 20%.  On the other hand, ML277 only mildly slows 
fluorescence deactivation, with an 88 ± 16% increase in time constant.  This effect is 
significantly smaller than that of the current deactivation.  We additionally measured the voltage-
dependence of fluorescence (FV) and conductance (GV) activation and found that ML277 does 
not significantly shift the GV nor FV.   
 
R-L3 slows voltage sensor deactivation with smaller effects on current deactivation 
To determine the gating effects of R-L3, we applied the same single pulse protocol, with 
the exception of introducing a prepulse at -120 mV to close channels more completely, and 
measured voltage sensor movement with ionic current.  We used 10 µM R-L3 in our 
experiments, which led to greater effects on deactivation and current amplitude than at lower 
concentrations.  We found that R-L3 significantly increased the current amplitude by 28 ± 4% 
and the time constant of current deactivation by 199 ± 22% (Fig. 3.4).  In contrast with ML277, 
R-L3 slows fluorescence deactivation more prominently, with a 335 ± 22% increase in the 
fluorescence deactivation time constant.  The percent change in fluorescence deactivation time 
constant is significantly greater than that of current deactivation.  In addition, R-L3 causes a 
significant hyperpolarizing shift in the GV by -6.0 ± 2.0 mV and in the FV by -13.8 ± 2.1 mV. 
 
Kinetic modeling informs distinct mechanisms of effect of ML277 and R-L3 
We modeled the effects of ML277 and R-L3 on channel gating using the same gating 
scheme described in previous chapters.  In this scheme, voltage sensor movement is represented 
by horizontal transitions and occurs in two steps: first, independent movement of four S4’s to an 
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intermediate state; second, a concerted step to the fully activated state (Fig. 3.5 a).  Our 
previously derived model of KCNQ1 shows that channel opening occurs mainly when some or 
all voltage sensors are in the intermediate state.  Each step in voltage sensor activation increases 
probability of channel opening in an allosteric manner.  
To simulate the gating effect of ML277, we slowed the pore opening and closing 
transitions in addition to increasing the current amplitude from our KCNQ1 model (Table S3).  
Figure 3.4.  R-L3 alters voltage sensor movement of KCNQ1.  (a-b) Current (a) and normalized fluorescence 
(b) traces of KCNQ1.  Cells were held at -80 mV, prepulsed to -120 mV for 2 s, depolarized to +20 mV for 2 s, 
and repolarized to -120 mV for 2 s to record tail currents.  (c) Comparing effect of R-L3 on current and 
fluorescence deactivation kinetics time constant (tau) at -120 mV.  Data are shown as mean ± SEM (error bars). 
*P<0.05; paired t-test.  (d-e) Normalized isochronal activation curves for conductance (d) and fluorescence (e). 
Lines represent fits of data.  Error bars represent SEM.  In the isochronal activation protocol, cells were held at -
80 mV, prepulsed to -120 mV for 2 s, stepped between -140 mV and +80 mV for 2 s, followed by a pulse to -120 
mV for 2 s.   
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We simulated current and fluorescence using same single pulse voltage protocol as our 
experiments.  In addition, we simulated FV and GV curves.  Our simulation shows slowing in 
both current activation and deactivation (Figure 3.5), similar to the effects of ML277.  The time 
constant of current deactivation slowing is increased by 363% and accompanied by a small 
(14%) increase in the time constant of fluorescence deactivation.  Furthermore, there is no 
change in the activation kinetics of fluorescence, similar to the VCF data.  In addition, there is no 
Figure 3.5.  Simulating the effects of ML277 using a kinetic model of KCNQ1.  (a) Model of KCNQ1 gating.  
In this model, horizontal transitions represent voltage sensor movement, while vertical transitions represent pore 
opening/closing.  Voltage sensors can exist in the resting (white), intermediate (red), or fully activated state 
(blue).  To simulate the effect of ML277, the pore opening/closing transition was slowed and current amplitude 
was increased.  Voltage sensor transitions were not altered.  (b-c) Simulated current (b) and fluorescence (c) 
using the same single pulse protocol as in VCF experiments.  (d) Percent increase in time constant of 
deactivation (tau) at -120 mV.  (e-f) Simulated isochronal activation for conductance (e) and fluorescence (f), 
using the same protocol as in VCF experiments.  (g) Simulating the effect of increased voltage sensor-pore 
coupling on fluorescence deactivation after pore transitions have been slowed. 
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shift in the GV nor FV curves.  Thus, merely slowing pore transitions recapitulates most 
observed effects of ML277.  
We simulated the effects of R-L3 by altering a different gating mechanism from that of 
ML277.  Instead of slowing pore opening/closing, we decreased the deactivation rate of the main 
voltage sensor transition by 240% in our model.  This increases the time constant of fluorescence 
deactivation by 224% and the time constant of current deactivation by 187% (Figure 3.6).  In 
addition, there is a small (2.9%) increase in current amplitude.  Furthermore, we found a 
hyperpolarizing shift in both the FV and GV by 18.5 mV and 18.1 mV, respectively.  These 
simulations recapitulate most of R-L3’s effects from our VCF data. 
 
Figure 3.6.  Simulating the effects of R-L3 using a kinetic model of KCNQ1.  In this simulation, the rate of 
voltage sensor deactivation was slowed.  Pore transitions were not altered.  (a-b) Simulated current (a) and 
fluorescence (b) using the same single pulse protocol as in VCF experiments.  (c) Percent increase in time 
constant of deactivation (tau) at -120 mV.  (d-e) Simulated isochronal activation for conductance (d) and 




Slowing of channel deactivation contributes to increased channel function and is an 
important property of molecular activators.  However, given the intricate gating processes of 
voltage-dependent channels, drugs may alter ionic currents through different mechanism.  Here, 
we have utilized VCF and kinetic modeling to illustrate two KCNQ1 activators with distinct 
effects on channel gating.  Our results suggest that on one hand, ML277 directly slows pore 
activation and deactivation.  On the other hand, R-L3 directly slows voltage sensor deactivation, 
which indirectly slows current deactivation.  These results show that molecular activators can 
slow KCNQ1 deactivation by different mechanisms and thus provides a key step toward 
investigating their effectiveness in rescuing distinct loss-of-function mutations.  Although the 
effects of both ML277 and R-L3 diminish with addition of the β-subunit KCNE1 and are 
therefore unlikely to be clinically useful, our studies provide generalizable insights on 
mechanisms of gain-of-function that can be applied in future efforts to modulating channel 
function. 
The pore effect of ML277 is supported our mutagenesis experiment, which demonstrates 
that the KCNQ1 pore domain is required for the action of ML277, including slowing of 
deactivation.  The slowing of pore deactivation indirectly causes a small slowing in voltage 
sensor deactivation according to our model.  This effect is mediated by the coupling between 
voltage sensor and the pore.  While coupling allows S4 activation to control the pore, Zaydman 
et al. previously demonstrated that the reverse process is also possible95.  They showed that 
locking KCNQ1’s pore in the open conformation stabilized voltage sensor activation.  We 
calculated transition rates in our model to show that in normal KCNQ1 deactivation, most S4 
transitions occur while the channel is closed (Supplementary Fig. S6).  After slowing pore 
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closing, the pathway of deactivation is altered such that most S4 deactivation occurs while the 
channel is open.  Because of retrograde coupling, this stabilizes voltage sensors in the activated 
state and slows voltage sensor deactivation.  In fact, when we increased the degree of voltage 
sensor-pore coupling in our model, we observed a greater slowing in voltage sensor deactivation 
(Fig. 3.5 g) that is more consistent with our data.  Given this, we propose that ML277 may alter 
voltage sensor-pore coupling in addition to its pore effects.  This coupling effect is supported by 
previous docking and molecular dynamics simulations in which ML277 interacts with the S4-S5 
linker199. 
Our VCF results and kinetic model suggest that R-L3 directly slows the deactivation rate 
of voltage sensors, which indirectly slows current deactivation.  This can be explained by 
examining the transition rates in the model (Supplementary Fig. S6).  During KCNQ1 
deactivation, the pore normally closes and reopens a number of times as voltage sensors 
deactivate.  Slowing the rate of voltage sensor deactivation increases the number of times the 
pore reopens, thereby slowing current deactivation.  In addition, slowing the rate of voltage 
sensor deactivation alters the equilibrium between voltage sensor activation and deactivation, 
thereby explaining the hyperpolarizing shift in the FV.  Since voltage sensor movement is 
coupled to the pore, the GV also left-shifts, resulting in a slight increase in current amplitude.  
However, given that the increase in amplitude is greater in our experiment compared to our 
model, an alternative explanation is likely required for this effect.  Previous studies have 
suggested that R-L3 binds to the channel pore.  Given this result, it is possible that R-L3 exerts 
two effects on KCNQ1: an effect on the pore to increase current amplitude, and an effect on 
voltage sensor movement to slow deactivation.  It remains to be explored whether these distinct 
functional effects result from R-L3 binding to multiple sites on KCNQ1, or from a single binding 
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site at the channel pore, where it may influence both pore and voltage sensor movement at the 
same time. 
In summary, results from mutagenesis, VCF, and kinetic modeling demonstrate distinct 
gating effects of two KCNQ1 activators that slow current deactivation.  On one hand, ML277 
directly slows pore closing, thereby slowing current deactivation.  On the other hand, R-L3 slows 
voltage sensor deactivation, which indirectly slows current deactivation.  These findings 
illustrate distinct mechanisms of channel gain-of-function and pave the way for future 




The slow delayed rectifier potassium current IKs plays a prominent physiological role by 
repolarizing the cardiac action potential.  Slowing of IKs deactivation increases channel function 
and underlies key pathophysiological processes and pharmacological action.  My thesis 
investigated the gating alterations underlying deactivations slowing, utilizing VCF to assay for 
voltage sensor movement simultaneously with ionic current through the channel pore.   
In Chapter 1, we examined the mechanisms of effect for two atrial fibrillation mutations, 
S140G and V141M, on KCNQ1 gating in the absence of KCNE1.  We showed that KCNQ1S140G 
directly slows voltage sensor deactivation, which indirectly slows current deactivation.  On the 
other hand, KCNQ1V141M has minimal effect on channel gating.  These results are consistent with 
previous structural information on KCNQ1, where S140 faces toward the voltage-sensing 
domain of the channel, whereas V141 faces away from the channel and toward membrane lipids, 
in close proximity to the putative location of KCNE1. 
In Chapter 2, we examined the gating alterations underlying deactivation slowing by 
atrial fibrillation mutations in the presence of KCNE1.  Surprisingly, both IKsS140G and IKsV141M 
alter the voltage sensor-pore coupling as well as slow the pore closing transition, resulting in 
pathways of deactivation in which channels can either re-open or stay open.  Although IKsS140G 
slows voltage sensor deactivation, our experiments and kinetic model show that this is an 
indirect effect of pore slowing, in contrast to KCNQ1S140G.  Taken together with results from 
Chapter 1, these data suggest that KCNE1 plays a critical role in mediating the coupling changes 
and pore effects in both IKsS140G and IKsV141M, leading to deactivation slowing.  We proposed a 
molecular mechanism in which both mutations disrupt the orientation of KCNE1 relative to 
KCNQ1 and thus impede gate closing.  These results imply that KCNE1 could serve as an 
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important pharmacologic target, either in correcting channel gain-of-function or rescuing channel 
loss-of-function. 
Pharmacologic activators, like atrial fibrillation mutations, can also cause deactivation 
slowing in KCNQ1.  In Chapter 3 we studied the gating mechanisms underlying deactivation 
slowing by ML277 and R-L3.  Our results show their distinct mechanisms of action on channel 
gating.  ML277 slows current activation and deactivation, with minimal effects on voltage sensor 
movement.  These effects are consistent with a direct slowing of pore transitions.  On the other 
hand, R-L3 slows voltage sensor deactivation with a smaller effect on current deactivation.  In 
addition, R-L3 causes a hyperpolarizing shift in voltage-dependence of activation for both 
voltage sensor movement and conductance.  These effects are consistent with a direct slowing of 
voltage sensor deactivation, which indirectly slows current deactivation.  Although the effects of 
ML277 and R-L3 are abolished by the presence of KCNE1, the gating mechanisms of these 
drugs in KCNQ1 provide insight on general mechanisms of channel activation that can guide 
future efforts to modulate channel function.   
Many antiarrhythmic agents can induce additional arrhythmia as side effects.  To 
optimize treatment, there is a great interest in understanding mechanism-based pharmacologic 
rescue of channel dysfunction.  The intricate gating mechanisms of voltage-dependent channels 
allow for different pathways of channel modulation.  The combined insights from our studies 
show that gain-of-function in a voltage-gated channel can be achieved by altering different 
gating processes: voltage sensor movement, pore opening/closing, and/or the coupling between 
voltage sensor and the pore.  Specific mechanisms of channel gain-of-function may be 
particularly effective for rescuing a given mechanism of channel loss-of-function.  An important 
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next step is to investigate whether small-molecule activators exhibit mutation-specificity in their 
abilities to rescue channel function. 
Slowing of IKs deactivation can occur outside the context of atrial fibrillation mutations 
and molecular activators.  As previously discussed, phosphorylation of KCNQ1 during 
adrenergic stimulation slows IKs deactivation and allows the cardiac action potential to adapt to 
elevated heart rates.  Dysfunction in adrenergic modification of KCNQ1 is closely associated 
with congenital LQTS.  However, the gating mechanisms underlying deactivation slowing by 
phosphorylation is unclear.  One hypothesis is that the addition of a negatively charged 
phosphate group influences the electrostatic environment of the voltage sensor, but this remains 
to be determined.  Our VCF and modeling studies provide a paradigm for studying modulation of 
channel gating and can be extended to examining the effects of phosphorylation. 
In summary, we have elucidated gating mechanisms that cause slowing of channel 
deactivation by atrial fibrillation mutations and small-molecule activators.  These results suggest 
the importance of a β-subunit in modulating pore motions and voltage sensor-pore coupling.  In 
addition, small-molecule activators can increase channel function by distinct gating mechanisms.  
Taken together, these results provide a key stepping stone in developing mechanism-specific 
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Appendix: Supplementary Figures and Tables 
A number of control experiments and supporting data are shown here.  Figure S1 
demonstrates that the current generated by VCF KCNQ1 constructs co-expressed with KCNE1 
can be blocked by Chromanol 293B.  Figure S2 shows that UCL2077, as previously shown, 
effectively inhibits IKs current.  In addition, the drug reduces the second component of 
fluorescence that is associated with channel opening.  Figure S3 compares the kinetics of 
fluorescence activation and deactivation between previously published VCF recordings and our 
kinetic model of IKs.  Figure S4 illustrates current traces and Rb+/K+ permeability ratios for true 
wildtype KCNQ1 and IKs.  The Rb+/K+ ratio for KCNQ1 is higher than for IKs, similar to the 
VCF constructs.  Figure S5 provides rate constants at -100 mV to help illustrate the deactivation 
pathways for our kinetic models of KCNQ1, IKs, and atrial fibrillation mutants.  Figure S6 
provides rate constants at -120 mV to help illustrate deactivation pathways for our kinetic models 
of KCNQ1 in the absence and presence of molecular activators.  Figure S7 provides the model 














Figure S1.  Chromanol 293B block of IKs and mutants.  Single pulse current recordings are shown for IKs, 
IKsS140G, and IKsV141M in control condition and following application of 100 µM Chromanol 293B, with the same 
KCNQ1 constructs as used in VCF experiments. 
Figure S2.  Effect of UCL2077 on IKs isochronal activation.  Cells were held at -110 mV, prepulsed to 
-140 mV to deactivate channels, followed by test pulses between +80 mV and -140 mV in intervals of 20 
mV, and then repolarized to -40 mV.  Fluorescence traces are shown in red whereas current traces are 




Figure S3.  Comparing previous VCF experimental results with simulation of IKs.  (a-h) Fluorescence traces 
recorded under four voltage protocols and corresponding plots of voltage-dependence of time constants for 
activation (b, f) and deactivation (d, h).  (i-p) Simulated fluorescence traces and voltage-dependence of time 





Figure S4.  Determining Rb+/K+ permeability ratio for true wildtype KCNQ1 and IKs.  Averaged current traces 







Figure S5.  Model rate constants at -100 mV for atrial fibrillation mutations.  Rate constants (in s-1) are 
calculated from model parameters for KCNQ1, IKs, and mutants.  For KCNQ1, the probability of channels existing 






Figure S6.  Model rate constants at -120 mV for molecular activators.  Rate constants (in s-1) are calculated from 
model parameters for KCNQ1 in the absence and presence of activators.  The probability of channels existing in 






Figure S7.  Model schematic. 
 
 
Table S1.  Simulation parameters for KCNQ1 in the absence of KCNE1. Values altered to simulate 
KCNQ1S140G are highlighted in yellow.  The parameter fl represents the fractional fluorescence of the first 





Table S2.  Simulation parameters for IKs. Values altered to simulate mutants are highlighted in yellow.  The 
parameter fl represents the fractional fluorescence of the first component of fluorescence. 
 
 
Table S3.  Simulation parameters for KCNQ1 and response to molecular activators. Values altered to simulate 
drug effects are highlighted in yellow.  The parameter fl represents the fractional fluorescence of the first component 
of fluorescence. 
 
